The plasma insulin responses of normal weight and obese, diabetic, and nondiabetic subjects to intravenous glucose was only 30-40% of that seen after oral glucose, indicating that alimentary mechanism(s) in addition to the arterial blood sugar concentration regulate insulin secretion. Observations made in subjects with diverted portal circulation indicate that the alimentary insulinogenic mechanism is located in the intestinal tract. The insulinogenic potency of the alimentary and glycemic stimuli expressed in terms of insulin secretion per gram of glucose were remarkably similar within each group of individuals. Between these groups, however, there were considerable differences. Obesity, with or without associated diabetes, was associated with a true hypersecretory responsiveness, whereas diabetes was characterized, with or without obesity, by a marked impairment in insulin secretion. The experimental design used in these studies permitted quantitation of the magnitude of the glycemic component of an oral glucose load. As a consequence of impaired insulin secretion, a greater than normal proportion of the oral glucose load escapes initial hepatic extraction in the maturity-onset diabetic and enters the peripheral circulation. Therefore, in the noninsulin-requiring maturity-onset diabetic, the glycemic insulinogenic stimulus for a given oral glucose load is significantly greater than in normal subjects and accounts for the excessive plasma insulin responses observed late in the course of an oral glucose tolerance test.
Michael J. Perley, David M. Kipnis
Year: | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980 | 1979 | 1978 | 1977 | 1976 | 1975 | 1974 | 1973 | 1972 | 1971 | 1970 | 1969 | 1968 | 1964 | 1957 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 7 | 8 | 6 | 16 | 15 | 12 | 13 | 12 | 25 | 20 | 10 | 21 | 16 | 17 | 45 | 14 | 26 | 28 | 23 | 14 | 11 | 9 | 5 | 6 | 2 | 9 | 3 | 5 | 6 | 2 | 7 | 5 | 6 | 6 | 5 | 3 | 8 | 8 | 14 | 9 | 7 | 13 | 10 | 8 | 15 | 10 | 17 | 9 | 5 | 11 | 7 | 13 | 13 | 17 | 18 | 15 | 4 | 1 | 1 | 671 |
Title and authors | Publication | Year |
---|---|---|
A role and mechanism for redox sensing by SENP1 in β-cell responses to high fat feeding.
Lin H, Suzuki K, Smith N, Li X, Nalbach L, Fuentes S, Spigelman AF, Dai XQ, Bautista A, Ferdaoussi M, Aggarwal S, Pepper AR, Roma LP, Ampofo E, Li WH, MacDonald PE |
Nature Communications | 2024 |
Metabolic hormones are integral regulators of female reproductive health and function.
Athar F, Karmani M, Templeman NM |
Bioscience Reports | 2024 |
Pancreatic β cell function versus insulin resistance: application of the hyperbolic law of glucose tolerance.
Bergman RN |
Journal of Clinical Investigation | 2024 |
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets
Reed J, Bain SC, Kanamarlapudi V |
2024 | |
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Liu QK |
Frontiers in Endocrinology | 2024 |
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t
Novikoff A, Müller TD |
Physiology | 2024 |
Impaired Incretin Homeostasis in Nondiabetic Moderate-to-Severe CKD
Ahmadi A, Gamboa J, Norman JE, Enkhmaa B, Tucker M, Bennett BJ, Zelnick LR, Fan S, Berglund LF, Ikizler TA, de Boer IH, Cummings BP, Roshanravan B |
Clinical Journal of the American Society of Nephrology : CJASN | 2024 |
Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor Agonists
Umapathysivam MM, Araldi E, Hastoy B, Dawed AY, Vatandaslar H, Sengupta S, Kaufmann A, Thomsen S, Hartmann B, Jonsson AE, Kabakci H, Thaman S, Grarup N, Have CT, Færch K, Gjesing AP, Nawaz S, Cheeseman J, Neville MJ, Pedersen O, Walker M, Jennison C, Hattersley AT, Hansen T, Karpe F, Holst JJ, Jones AG, Ristow M, McCarthy MI, Pearson ER, Stoffel M, Gloyn AL |
2023 | |
Beta Cell Dysfunction in Youth- and Adult-Onset Type 2 Diabetes: An Extensive Narrative Review with a Special Focus on the Role of Nutrients
Serbis A, Giapros V, Tsamis K, Balomenou F, Galli-Tsinopoulou A, Siomou E |
Nutrients | 2023 |
DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature.
Saini K, Sharma S, Khan Y |
Frontiers in Molecular Biosciences | 2023 |
The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD.
Petrovic A, Igrec D, Rozac K, Bojanic K, Kuna L, Kolaric TO, Mihaljevic V, Sikora R, Smolic R, Glasnovic M, Wu GY, Smolic M |
Current issues in molecular biology | 2023 |
Assessment of the incretin effect in healthy subjects: concordance between clamp and OGTT methods.
Aulinger BA, D'Alessio DA |
American journal of physiology. Endocrinology and metabolism | 2023 |
Impaired incretin homeostasis in non-diabetic moderate-severe CKD
Ahmadi A, Gamboa J, Norman JE, Enkhmaa B, Tucker M, Bennett BJ, Zelnick LR, Fan S, Berglund LF, Ikizler TA, de Boer IH, Cummings BP, Roshanravan B |
2023 | |
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets
Folli F, Finzi G, Manfrini R, Galli A, Casiraghi F, Centofanti L, Berra C, Fiorina P, Davalli A, La Rosa S, Perego C, Higgins PB |
American journal of physiology. Endocrinology and metabolism | 2023 |
An extended minimal model of OGTT: estimation of α- and β-cell dysfunction, insulin resistance, and the incretin effect
Subramanian V, Bagger JI, Harihar V, Holst JJ, Knop FK, Villsbøll T |
American journal of physiology. Endocrinology and metabolism | 2023 |
Nutrient Regulation of Pancreatic Islet β-Cell Secretory Capacity and Insulin Production
K Rohli, C Boyer, S Blom, S Stephens |
Biomolecules | 2022 |
Role of the gut–brain axis in energy and glucose metabolism
H Wachsmuth, S Weninger, F Duca |
Experimental & molecular medicine | 2022 |
The Enteroendocrine System in Obesity.
Miedzybrodzka EL, Reimann F, Gribble FM |
Handbook of experimental pharmacology | 2022 |
Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment.
Florentin M, Kostapanos MS, Papazafiropoulou AK |
World journal of diabetes | 2022 |
Revisiting the concept of incretin and enteroendocrine L-cells as type 2 diabetes mellitus treatment.
Lok KH, Wareham NJ, Nair RS, How CW, Chuah LH |
Pharmacological Research | 2022 |
Chronic Kidney Disease is Associated With Attenuated Plasma Metabolome Response to Oral Glucose Tolerance Testing
Ahmadi A, Huda MN, Bennett BJ, Gamboa J, Zelnick LR, Smith LR, Chondronikola M, Raftery D, de Boer IH, Roshanravan B |
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation | 2022 |
Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes
E Grespan, T Giorgino, A Natali, E Ferrannini, A Mari |
Metabolism | 2021 |
New Aspects of Diabetes Research and Therapeutic Development
LS Satin, SA Soleimanpour, EM Walker, L Isom |
Pharmacological reviews | 2021 |
Non-glucose modulators of insulin secretion in healthy humans: (dis)similarities between islet and in vivo studies
JC Henquin |
Metabolism | 2021 |
β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances
N Mukherjee, L Lin, CJ Contreras, AT Templin |
Metabolites | 2021 |
The evolving story of incretins ( GIP and GLP ‐1) in metabolic and cardiovascular disease: A pathophysiological update
MA Nauck, DR Quast, J Wefers, AF Pfeiffer |
Diabetes, obesity & metabolism | 2021 |
SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
L D'Marco, V Morillo, JL Gorriz, MK Suarez, M Nava, Á Ortega, H Parra, N Villasmil, J Rojas-Quintero, V Bermúdez, M Wallner |
Journal of Diabetes Research | 2021 |
miR-344-5p Modulates Cholesterol-Induced β-Cell Apoptosis and Dysfunction Through Regulating Caveolin-1 Expression
X Sun, G Ji, P Li, W Li, J Li, L Zhu |
Frontiers in Endocrinology | 2021 |
Beinaglutide shows significantly beneficial effects in diabetes/obesity-induced nonalcoholic steatohepatitis in ob/ob mouse model
X Fang, Z Du, C Duan, S Zhan, T Wang, M Zhu, J Shi, J Meng, X Zhang, M Yang, Y Zuo |
Life Sciences | 2021 |
Regulation of Postabsorptive and Postprandial Glucose Metabolism by Insulin-Dependent and Insulin-Independent Mechanisms: An Integrative Approach
GD Dimitriadis, E Maratou, A Kountouri, M Board, V Lambadiari |
Nutrients | 2021 |
Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose
Y Zhang, C Han, W Zhu, G Yang, X Peng, S Mehta, J Zhang, L Chen, Y Liu |
Cells | 2021 |
The Role of Incretins on Insulin Function and Glucose Homeostasis
JJ Holst, LS Gasbjerg, MM Rosenkilde |
Endocrinology | 2021 |
A Century of Insulin: Outstanding Physiological Breakthroughs
A Matveyenko, G Sieck, A Klip |
Physiology (Bethesda, Md.) | 2021 |
A STUDY OF SERUM URIC ACID LEVELS IN TYPE 2 DIABETES MELLITUS CASES AND ITS COMPARISON WITH THE SERUM CREATININE LEVELS
S Shajahan, KS Lahari, P Kiranmai |
2021 | |
Management of Nutritional and Metabolic Complications of Bariatric Surgery
AG Bhasker, N Kantharia, S Baig, P Priya, M Lakdawala, MS Sancheti |
2021 | |
Sugar Intake - Risks and Benefits and the Global Diabetes Epidemic
IJ Martins |
2021 | |
Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment.
Pelle MC, Provenzano M, Zaffina I, Pujia R, Giofrè F, Lucà S, Andreucci M, Sciacqua A, Arturi F |
2021 | |
Development of innovative tools for investigation of nutrient-gut interaction
WK Huang, C Xie, RL Young, JB Zhao, H Ebendorff-Heidepriem, KL Jones, CK Rayner, TZ Wu |
World journal of gastroenterology : WJG | 2020 |
The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship
MA Nauck |
Metabolism | 2020 |
Acute Effects of Insulin on Cardiac Function in Patients with Diabetes Mellitus: Clinical Applicability and Feasibility
DD Naccache, S Yalonetsky, RB Yoseph |
International Journal of Endocrinology | 2020 |
Recent advances in understanding the role of glucagon-like peptide 1
J Reed, S Bain, V Kanamarlapudi |
F1000Research | 2020 |
An alternative pathway for sweet sensation: possible mechanisms and physiological relevance
E von Molitor, K Riedel, M Krohn, R Rudolf, M Hafner, T Cesetti |
Pflügers Archiv - European Journal of Physiology | 2020 |
Primary, Secondary, and Tertiary Effects of Carbohydrate Ingestion During Exercise
I Rollo, JT Gonzalez, CJ Fuchs, LJ van Loon, C Williams |
Sports Medicine | 2020 |
Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report
JN Corcoran, KJ Jacoby, TD Olives, SA Bangh, JB Cole |
Journal of Medical Toxicology | 2020 |
Withdrawal of medications leads to worsening of OGTT parameters in youth with impaired glucose tolerance or recently‐diagnosed type 2 diabetes
TS Hannon, SL Edelstein, SA Arslanian, S Caprio, PS Zeitler, TA Buchanan, DA Ehrmann, KJ Mather, M Tripputi, SE Kahn, KJ Nadeau, DA Ehrmann, KA Temple, A Rue, E Barengolts, B Mokhlesi, EV Cauter, S Sam, MA Miller, SE Kahn, KM Atkinson, JP Palmer, KM Utzschneider, T Gebremedhin, A KernanSchloss, A Kozedub, BK Montgomery, EJ Morse, KJ Mather, T Garrett, TS Hannon, A Lteif, A Patel, R Chisholm, K Moore, V Pirics, L Pratt, KJ Nadeau, S Gross, PS Zeitler, J Williams, M CreeGreen, YG Reyes, K Vissat, SA Arslanian, K Brown, N Guerra, K Porter, S Caprio, M Savoye, B Pierpont, TA Buchanan, AH Xiang, E Trigo, E Beale, FN Hendee, N Katkhouda, K Nayak, M Martinez, C Montgomery, X Wang, SL Edelstein, JM Lachin, AH Tjaden, M Tripputi, LE ghormli, S Marcovina, J Harting, J Albers, D Hill, PJ Savage, EW Leschek |
Pediatric Diabetes | 2020 |
Surgical Metabolism: The Metabolic Care of the Surgical Patient
KA Davis, SH Rosenbaum |
2020 | |
The insulinotropic and incretin response to feeding a milk based protein matrix in healthy young women
M Amigo-Benavent, O Power-Grant, RJ FitzGerald, P Jakeman |
Journal of Functional Foods | 2020 |
The regulation of gastric ghrelin secretion
M NunezSalces, H Li, C FeinleBisset, RL Young, AJ Page |
Acta physiologica (Oxford, England) | 2020 |
Effect of free fatty acids on insulin secretion, insulin sensitivity and incretin effect – a narrative review
VB Chueire, E Muscelli |
Archives of Endocrinology and Metabolism | 2020 |
Measuring Insulin Resistance in Humans
VR Sharma, ST Matta, MW Haymond, ST Chung |
Hormone Research in Pædiatrics | 2020 |
Insulin sensitivity depends on the route of glucose administration
G Mingrone, S Panunzi, AD Gaetano, S Ahlin, V Spuntarelli, I Bondia-Pons, C Barbieri, E Capristo, A Gastaldelli, JJ Nolan |
Diabetologia | 2020 |
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps
JI Mechanick, ME Farkouh, JD Newman, WT Garvey |
Journal of the American College of Cardiology | 2020 |
Glucagon-like peptide 1 (GLP-1)
TD Müller, B Finan, SR Bloom, D D'Alessio, DJ Drucker, PR Flatt, A Fritsche, F Gribble, HJ Grill, JF Habener, JJ Holst, W Langhans, JJ Meier, MA Nauck, D Perez-Tilve, A Pocai, F Reimann, DA Sandoval, TW Schwartz, RJ Seeley, K Stemmer, M Tang-Christensen, SC Woods, RD DiMarchi, MH Tschöp |
Molecular Metabolism | 2019 |
Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment
SP Schiellerup, K Skov-Jeppesen, JA Windeløv, MS Svane, JJ Holst, B Hartmann, MM Rosenkilde |
Frontiers in Endocrinology | 2019 |
The Incretin Effect in Female Mice With Double Deletion of GLP-1 and GIP Receptors
B Ahrén, Y Yamada, Y Seino |
Journal of the Endocrine Society | 2019 |
MicroRNA miR-7 Regulates Secretion of Insulin-Like Peptides
P Agbu, JJ Cassidy, J Braverman, A Jacobson, RW Carthew |
Endocrinology | 2019 |
From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
JJ Holst |
Frontiers in Endocrinology | 2019 |
Comparison of biochemical parameters among DPP4 inhibitor users and other oral hypoglycaemic drug users: a cross-sectional study from Anuradhapura, Sri Lanka
D Rathish, C Jayasumana, S Agampodi |
Journal of Health, Population and Nutrition | 2019 |
Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes
DK Mandaliya, S Seshadri |
Pancreatology | 2019 |
Incretin Physiology and Pharmacology in the Intensive Care Unit
MP Plummer, J Hermanides, AM Deane |
Critical Care Clinics | 2019 |
CA125 over‐release behavior following a 75‐g oral glucose test as a predictive biomarker of multidrug resistance in patients with ovarian cancer
Y He, Z Gu, Q Zhu, M Chen, C He, Y Huang, Q Li, W Di |
International Journal of Cancer | 2019 |
In vivo, ex vivo and in vitro evidence for atropine-mediated attenuation of glucagon-like peptide-1 secretion: findings from a systematic review
D Rathish, S Agampodi, C Jayasumana |
Environmental Science and Pollution Research | 2019 |
Effects of an 8-week community exercise program on health-related physical fitness in overweight and obese working adults
NA Roslan, AH Mokhtar |
2019 | |
DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment
M Mikov, N Pavlović, B Stanimirov, M Đanić, S Goločorbin-Kon, K Stankov, H Al-Salami |
European Journal of Drug Metabolism and Pharmacokinetics | 2019 |
What Has Bariatric Surgery Taught Us About the Role of the Upper Gastrointestinal Tract in the Regulation of Postprandial Glucose Metabolism?
J Ma, A Vella |
Frontiers in Endocrinology | 2018 |
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
S Paternoster, M Falasca |
Frontiers in Endocrinology | 2018 |
Increase in hepatic and decrease in peripheral insulin clearance characterize abnormal temporal patterns of serum insulin in diabetic subjects
K Ohashi, M Fujii, S Uda, H Kubota, H Komada, K Sakaguchi, W Ogawa, S Kuroda |
npj Systems Biology and Applications | 2018 |
The effects of kisspeptin on β-cell function, serum metabolites and appetite in humans
C Izzi-Engbeaya, AN Comninos, SA Clarke, A Jomard, L Yang, S Jones, A Abbara, S Narayanaswamy, PC Eng, D Papadopoulou, JK Prague, P Bech, IF Godsland, P Bassett, C Sands, S Camuzeaux, M Gomez-Romero, JT Pearce, MR Lewis, E Holmes, JK Nicholson, T Tan, R Ratnasabapathy, M Hu, G Carrat, L Piemonti, M Bugliani, P Marchetti, PR Johnson, SJ Hughes, AM Shapiro, GA Rutter, WS Dhillo |
Diabetes, obesity & metabolism | 2018 |
Incretin responses to oral glucose and mixed meal tests and changes in fasting glucose levels during 7 years of follow-up: The Hoorn Meal Study
AD Koopman, F Rutters, SP Rauh, G Nijpels, JJ Holst, JW Beulens, M Alssema, JM Dekker, S Kaser |
PloS one | 2018 |
The Origin and Understanding of the Incretin Concept
JF Rehfeld |
Frontiers in Endocrinology | 2018 |
A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects
I Ikushima, L Jensen, A Flint, T Nishida, J Zacho, S Irie |
Advances in Therapy | 2018 |
The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction
JD Newman, AK Vani, JO Aleman, HS Weintraub, JS Berger, AZ Schwartzbard |
Journal of the American College of Cardiology | 2018 |
Differential GIP/GLP-1 intestinal cell distribution in diabetics’ yields distinctive rearrangements depending on Roux-en-Y biliopancreatic limb length
AM Palha, SS Pereira, MM Costa, T Morais, AF Maia, M Guimarães, M Nora, MP Monteiro |
Journal of Cellular Biochemistry | 2018 |
A low GLP-1 response among patients treated for acute organophosphate and carbamate poisoning: a comparative cross-sectional study from an agrarian region of Sri Lanka
D Rathish, I Senavirathna, C Jayasumana, S Agampodi, S Siribaddana |
Environmental Science and Pollution Research | 2018 |
Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
F Bifari, R Manfrini, MD Cas, C Berra, M Siano, M Zuin, R Paroni, F Folli |
Pharmacological research : the official journal of the Italian Pharmacological Society | 2018 |
Bariatric surgery as a model to explore the basis and consequences of the Reaven hypothesis: Small, dense low-density lipoprotein and interleukin-6
S Adam, Y Liu, T Siahmansur, JH Ho, SS Dhage, R Yadav, JP New, R Donn, BJ Ammori, AA Syed, RA Malik, H Soran, PN Durrington |
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease | 2018 |
Glucagon Switches between GLP-1 and Glucagon Receptors in Normal and Hyperglycemic Mice
C Han, Y Zhang, W Zhu, G Yang, X Peng, S Mehta, J Zhang, Y Liu, L Chen |
SSRN Electronic Journal | 2018 |
Outcomes of One Anastomosis Gastric Bypass in 472 Diabetic Patients
O Taha, M Abdelaal, M Abozeid, A Askalany, M Alaa |
Obesity Surgery | 2017 |
G Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
DM Riddy, P Delerive, RJ Summers, PM Sexton, CJ Langmead, EL Barker |
Pharmacological reviews | 2017 |
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
MH Muskiet, L Tonneijck, MM Smits, MJ van Baar, MH Kramer, EJ Hoorn, JA Joles, DH van Raalte |
Nature Reviews Nephrology | 2017 |
The α-glucosidase inhibitor voglibose stimulates delayed gastric emptying in healthy subjects: a crossover study with a 13C breath test
K Kanoshima, M Matsuura, M Kaai, Y Inoh, K Ohkuma, H Iida, T Nonaka, K Fujita, T Ida, A Kusakabe, A Nakajima, M Inamori |
Journal of Clinical Biochemistry and Nutrition | 2017 |
A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?
G Chikara, PK Sharma, P Dwivedi, J Charan, S Ambwani, S Singh |
Indian Journal of Clinical Biochemistry | 2017 |
RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes
VA Gault |
Diabetic Medicine | 2017 |
Impact of Abdominal Subcutaneous Fat Reduction on Glycemic Control in Obese Patients with Type 2 Diabetes Mellitus
AH Abdelhafez, O Taha, M Abdelaal, W Al-Najim, CW le Roux, NG Docherty |
Bariatric Surgical Practice and Patient Care | 2017 |
TEMPORARY REMOVAL: Rebirth of the Incretin Concept: Its conception and early development
V Marks |
Peptides | 2017 |
Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes
JA Lovshin |
Canadian Journal of Diabetes | 2017 |
Attenuated diuresis and natriuresis in response to glucagon-like peptide-1 in hypertensive rats are associated with lower expression of the glucagon-like peptide-1 receptor in the renal vasculature
FA Savignano, RO Crajoinas, BP Pacheco, LC Campos, MH Shimizu, AC Seguro, AC Girardi |
European Journal of Pharmacology | 2017 |
WITHDRAWN: Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes
JA Lovshin |
Canadian Journal of Diabetes | 2017 |
A Machine Learning Approach to Detecting Sensor Data Modification Intrusions in WBANs
A Verner, D Butvinik |
2017 | |
The incretin hormone GLP-1 and mechanisms underlying its secretion: Hormone GLP-1 and its secretion
L Tian, T Jin |
Journal of Diabetes | 2016 |
The Macronutrients, Appetite, and Energy Intake
AL Carreiro, J Dhillon, S Gordon, KA Higgins, AG Jacobs, BM McArthur, BW Redan, RL Rivera, LR Schmidt, RD Mattes |
Annual Review of Nutrition | 2016 |
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes
C Graaf, D Donnelly, D Wootten, J Lau, PM Sexton, LJ Miller, JM Ahn, J Liao, MM Fletcher, D Yang, AJ Brown, C Zhou, J Deng, MW Wang |
Pharmacological reviews | 2016 |
Roles of the Gut in Glucose Homeostasis
JJ Holst, F Gribble, M Horowitz, CK Rayner |
Diabetes care | 2016 |
The biology of glucagon and the consequences of hyperglucagonemia
NJ Albrechtsen, RE Kuhre, J Pedersen, FK Knop, JJ Holst |
Biomarkers in Medicine | 2016 |
Bariatric surgery and obesity: influence on the incretins
B Laferrère |
International Journal of Obesity Supplements | 2016 |
Endocrinology: Adult and Pediatric
M Gurnell, TJ Visser, P Beck-Peccoz, VK Chatterjee |
Endocrinology: Adult and Pediatric | 2016 |
Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies
CF Shaefer |
Clinical diabetes : a publication of the American Diabetes Association | 2016 |
Interactions between kidney disease and diabetes: dangerous liaisons
R Pecoits-Filho, H Abensur, CC Betônico, AD Machado, EB Parente, M Queiroz, JE Salles, S Titan, S Vencio |
Diabetology & metabolic syndrome | 2016 |
The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?
BA Aulinger, TP Vahl, RL Prigeon, DA D'Alessio, DA Elder |
American journal of physiology. Endocrinology and metabolism | 2016 |
From organophosphate poisoning to diabetes mellitus: The incretin effect
D Rathish, SB Agampodi, MA Jayasumana, SH Siribaddana |
Medical Hypotheses | 2016 |
Albiglutide: Is a better hope against diabetes mellitus?
AK Sharma, PV Thanikachalam, SK Rajput |
Biomedicine & Pharmacotherapy | 2016 |
Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): a randomized trial
ST Azar, A Echtay, WM Bebakar, SA Araj, A Berrah, M Omar, A Mutha, K Tornøe, MS Kaltoft, N Shehadeh |
Diabetes Obesity and Metabolism | 2016 |
Cholesteryl Ester Transfer Protein (CETP) expression does not affect glucose homeostasis and insulin secretion: studies in human CETP transgenic mice
HF Raposo, EC Vanzela, JA Berti, HC Oliveira |
Lipids in Health and Disease | 2016 |
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future
S Kalra, MP Baruah, RK Sahay, AG Unnikrishnan, S Uppal, O Adetunji |
Indian journal of endocrinology and metabolism | 2016 |
Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men
N Matikainen, E Björnson, S Söderlund, C Borén, B Eliasson, KH Pietiläinen, LH Bogl, A Hakkarainen, N Lundbom, A Rivellese, G Riccardi, JP Després, N Alméras, JJ Holst, CF Deacon, J Borén, MR Taskinen, K Maedler |
PloS one | 2016 |
Histoire des incrétines : Du chien brun au monstre de Gila
JL Schlienger |
Médecine des Maladies Métaboliques | 2016 |
Glucometabolic gut hormones: beyond the incretin effect
DP Sonne |
Cardiovascular Endocrinology | 2016 |
Principles of Diabetes Mellitus
A Ohri, S Vergano, R Bhambri, SH Schneider |
Principles of Diabetes Mellitus | 2016 |
Third Exposure to a Reduced Carbohydrate Meal Lowers Evening Postprandial Insulin and GIP Responses and HOMA-IR Estimate of Insulin Resistance
PJ Lin, KT Borer, D Thompson |
PloS one | 2016 |
Incretin – based therapy in diabetes mellitus: present scenario and expanding horizons
SC Kohli |
Nepal Journal of Epidemiology | 2016 |
Endocrinology
C Napier, SH Pearce |
Endocrinology | 2016 |
Systems Pharmacology and Pharmacodynamics
DE Mager, HH Kimko |
Systems Pharmacology and Pharmacodynamics | 2016 |
Metabolic Syndrome and Diabetes
M Kurian, BM Wolfe, S Ikramuddin |
2016 | |
The Stress Response of Critical Illness: Metabolic and Hormonal Aspects
JC Preiser |
2016 | |
cAMP-independent effects of GLP-1 on β cells
Jelena Kolic, Patrick MacDonald |
Journal of Clinical Investigation | 2015 |
Stimulation of incretin secreting cells
R Pais, FM Gribble, F Reimann |
Therapeutic Advances in Endocrinology and Metabolism | 2015 |
New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders
N Irwin |
World journal of diabetes | 2015 |
Activation of Melatonin Signaling Promotes β-Cell Survival and Function
S Costes, M Boss, AP Thomas, AV Matveyenko |
Molecular Endocrinology | 2015 |
Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study
A Myat, S Arri, DL Bhatt, BJ Gersh, SR Redwood, MS Marber |
Cardiovascular Diabetology | 2015 |
Reduction of insulinotropic properties of GLP-1 and GIP after glucocorticoid-induced insulin resistance
M Eriksen, DH Jensen, S Tribler, JJ Holst, S Madsbad, T Krarup |
Diabetologia | 2015 |
Exenatide once-weekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectives
W Deng, S Qiu, G Yang, B Chen |
Therapeutics and Clinical Risk Management | 2015 |
Evolving Paradigms in the Nutritional Support of Critically Ill Surgical Patients
MD Rosenthal, EL Vanzant, RG Martindale, FA Moore |
Current Problems in Surgery | 2015 |
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition
RN Bergman, M Ader |
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition | 2015 |
Detailed characterization of incretin cell distribution along the human small intestine
TP Guedes, S Martins, M Costa, SS Pereira, T Morais, A Santos, M Nora, M Monteiro |
Surgery for Obesity and Related Diseases | 2015 |
A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects
O Vahidi, KE Kwok, RB Gopaluni, FK Knop |
Medical & Biological Engineering & Computing | 2015 |
The incretin effect in critically ill patients: a case–control study
ST Nielsen, S Janum, R Krogh-Madsen, TP Solomon, K Møller |
Critical Care | 2015 |
Linagliptin/metformin HCl (fixed combination therapy) for the treatment of Type 2 diabetes mellitus
A Bhargava |
Expert Review of Endocrinology & Metabolism | 2015 |
Chirurgie bariatrique et insulinosécrétion : Où en est-on ?
F Andreelli |
Médecine des Maladies Métaboliques | 2015 |
Relief of diabetes by duodenal‑jejunal bypass sleeve implantation in the high‑fat diet and streptozotocin‑induced diabetic rat model is associated with an increase in GLP‑1 levels and the number of GLP‑1‑positive cells
J Shuang, Y Zhang, L Ma, X Tan, J Huang, X Wang, G Xiong, Z Jiang, X Zhang, S Du, Y Gu, X Shi, Z Fan |
Experimental and therapeutic medicine | 2015 |
Technosphere Inhaled Insulin: Is Faster Better?
JL Leahy |
Diabetes care | 2015 |
Glucose metabolism and production of incretins in patients with obesity and type 2 diabetes mellitus after Biliopancreatic bypass surgery in the modification of Hess-Marceau the early stages of postoperative monitoring
II Dedov, EA Troshina, EV Ershova, YI Yashkov |
Obesity and metabolism | 2015 |
Oxidative stress contributes to abnormal glucose metabolism and insulin sensitivity in two hyperlipidemia models
Jiefei Bai, Shuang Zheng, Dongdong Jiang, Tingting Han, Yangxue Li, Yao Zhang, Wei Liu, Yunshan Cao, Yaomin Hu |
International journal of clinical and experimental pathology | 2015 |
Diet and Nutrition in Critical Care
D Youssef, K Amrein, C Schnedl, H Dobnig, AN Peiris |
Diet and Nutrition in Critical Care | 2015 |
Synthesis and Evaluation of Optical and PET GLP-1 Peptide Analogues for GLP-1R Imaging
BB Azad, V Rota, L Yu, R Mcgirr, AH Amant, TY Lee, S Dhanvantari, LG Luyt |
Molecular imaging | 2015 |
Small Intestinal Glucose Exposure Determines the Magnitude of the Incretin Effect in Health and Type 2 Diabetes
CS Marathe, CK Rayner, M Bound, H Checklin, S Standfield, J Wishart, K Lange, KL Jones, M Horowitz |
Diabetes | 2014 |
Short-Term Outcomes of Laparoscopic Single Anastomosis Gastric Bypass (LSAGB) for the Treatment of Type 2 Diabetes in Lower BMI (<30 kg/m2) Patients
MJ Kim, KY Hur |
Obesity Surgery | 2014 |
Incretins and the intensivist: what are they and what does an intensivist need to know about them?
MP Plummer, MJ Chapman, M Horowitz, AM Deane |
Critical Care | 2014 |
Comprehensive Physiology
SN Cheuvront, RW Kenefick |
Comprehensive Physiology | 2014 |
Effect of Insulin-Induced Hypoglycaemia on the Central Nervous System: Evidence from Experimental Studies
VF Jensen, IB Bøgh, J Lykkesfeldt |
Journal of Neuroendocrinology | 2014 |
MECHANISMS IN ENDOCRINOLOGY: Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion
DP Sonne, M Hansen, FK Knop |
European Journal of Endocrinology | 2014 |
The neuro-incretin concept
B Ahrén |
Regulatory Peptides | 2014 |
Measurement of the Incretin Hormones: Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide
RE Kuhre, NJ Albrechtsen, B Hartmann, CF Deacon, JJ Holst |
2014 | |
Review: Surgical Treatment of Type 2 Diabetes
MD Gil, PP Alarcón, AL Ruiz, MÁ Ibañez, AH Torres, AB Cascales |
Pharmacology & Pharmacy | 2014 |
Network Identification of Hormonal Regulation
DJ Vis, JA Westerhuis, HC Hoefsloot, F Roelfsema, J der Greef, MM Hendriks, AK Smilde, P Holme |
PloS one | 2014 |
From gut changes to type 2 diabetes remission after gastric bypass surgeries
B Li, X Zhou, J Wu, H Zhou |
Frontiers of Medicine | 2013 |
A hydrophobic site on the GLP-1 receptor extracellular domain orients the peptide ligand for signal transduction
JT Patterson, P Li, JW Day, VM Gelfanov, RD DiMarchi |
Molecular Metabolism | 2013 |
Cholesterol reduction ameliorates glucose-induced calcium handling and insulin secretion in islets from low-density lipoprotein receptor knockout mice
JC Souza, EC Vanzela, RA Ribeiro, LF Rezende, CA Oliveira, EM Carneiro, HC Oliveira, AC Boschero |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2013 |
Mechanisms and Clinical Efficacy of Lixisenatide for the Management of Type 2 Diabetes
M Horowitz, CK Rayner, KL Jones |
Advances in Therapy | 2013 |
Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration
AI Duarte, E Candeias, SC Correia, RX Santos, C Carvalho, S Cardoso, A Plácido, MS Santos, CR Oliveira, PI Moreira |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2013 |
Antidiabetic agents: past, present and future
A Mehanna |
Future Medicinal Chemistry | 2013 |
New Incretin Hormonal Therapies in Humans Relevant to Diabetic Cats
CE Reusch, I Padrutt |
Veterinary Clinics of North America Small Animal Practice | 2013 |
Once weekly exenatide: efficacy, tolerability and place in therapy
C Wysham, M Grimm, S Chen |
Diabetes, Obesity and Metabolism | 2013 |
Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes
MW Stolar, M Grimm, S Chen |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2013 |
Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
AB Petersen, M Christensen |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2013 |
Enteroendocrine hormone mimetics for the treatment of obesity and diabetes
N Irwin, PR Flatt |
Current Opinion in Pharmacology | 2013 |
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety
CF Deacon, JJ Holst |
Expert Opinion on Pharmacotherapy | 2013 |
Paradoxical second-meal phenomenon in the acute post-exercise period
JT Gonzalez |
Nutrition | 2013 |
Incretin levels 1 month after laparoscopic single anastomosis gastric bypass surgery in non-morbid obese type 2 diabetes patients
MJ Kim, HK Park, DW Byun, KI Suh, KY Hur |
Asian Journal of Surgery | 2013 |
Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis
C Hales, D Barker |
International Journal of Epidemiology | 2013 |
Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes
O Power, AB Nongonierma, P Jakeman, RJ FitzGerald |
Proceedings of the Nutrition Society | 2013 |
Defining the Role of GLP-1 in the Enteroinsulinar Axis in Type 2 Diabetes Using DPP-4 Inhibition and GLP-1 Receptor Blockade
BA Aulinger, A Bedorf, G Kutscherauer, J Heer, JJ Holst, B Goke, J Schirra |
Diabetes | 2013 |
Pleiotropic Effects of GLP-1. Cardiovascular Evidence of Effectiveness
PP Alarcón, AB Cascales, AL Ruiz, MÁ Gil, AH Torres, MD Gil |
Pharmacology & Pharmacy | 2013 |
Incretins: Player or Stayer?
AM Deane, M Horowitz |
Journal of Intensive Care Medicine | 2013 |
Glucose Metabolism in Critically Ill Patients: Are Incretins an Important Player?
ST Nielsen, R Krogh-Madsen, K Møller |
Journal of Intensive Care Medicine | 2013 |
Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways
M Nishizawa, H Nakabayashi, K Uehara, A Nakagawa, K Uchida, D Koya |
American journal of physiology. Endocrinology and metabolism | 2013 |
Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
FS Willard, KW Sloop |
Experimental Diabetes Research | 2012 |
Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes
DH Jensen, K Aaboe, JE Henriksen, A Vølund, JJ Holst, S Madsbad, T Krarup |
Diabetologia | 2012 |
Incretins as a novel therapeutic strategy in patients with diabetes and heart failure
MA Khan, C Deaton, MK Rutter, L Neyses, MA Mamas |
Heart Failure Reviews | 2012 |
Incretin-based therapies
AH Stonehouse, T Darsow, DG Maggs |
Journal of Diabetes | 2012 |
Uncoupling protein 2 negatively regulates glucose-induced glucagon-like peptide 1 secretion
H Zhang, J Li, X Liang, Y Luo, K Zen, CY Zhang |
Journal of Molecular Endocrinology | 2012 |
Acute and chronic administration of SHR117887, a novel and specific dipeptidyl peptidase-4 inhibitor, improves metabolic control in diabetic rodent models
X Liu, L Zhang, Y Feng, L Zhang, H Qu, G Cao, Y Leng |
Acta Pharmacologica Sinica | 2012 |
Synergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice
L Ahlkvist, J Vikman, G Pacini, B Ahrén |
Regulatory Peptides | 2012 |
Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors:
LK Golightly, CC Drayna, MT McDermott |
Clinical Pharmacokinetics | 2012 |
Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors
LK Golightly, CC Drayna, MT McDermott |
Clinical Pharmacokinetics | 2012 |
Elucidation of the function and role of cAMP sensor Epac2A in insulin secretion
T Shibasaki |
Diabetology International | 2012 |
Expression profiling identifies novel gene targets and functions for Pdx1 in the duodenum of mature mice
C Chen, E Sibley |
AJP Gastrointestinal and Liver Physiology | 2012 |
Slowly and rapidly digestible starchy foods can elicit a similar glycemic response because of differential tissue glucose uptake in healthy men
C Eelderink, M Schepers, T Preston, RJ Vonk, L Oudhuis, MG Priebe |
The American journal of clinical nutrition | 2012 |
Doves, Diplomats, and Diabetes
M Watve |
2012 | |
Chronobiology and Obesity
M Garaulet, JM Ordovás |
2012 | |
Principles of Metabolic Surgery
WK Karcz, O Thomusch |
2012 | |
Incretins and their influence on the course of type 2 diabetes in patients with morbid obesity after bariatric oper
II Dedov, YI Yashkov, EV Ershova |
Obesity and metabolism | 2012 |
Inflammation of the Hypothalamus Leads to Defective Pancreatic Islet Function*
VC Calegari, AS Torsoni, EC Vanzela, EP Araújo, J Morari, CC Zoppi, L Sbragia, AC Boschero, LA Velloso |
The Journal of biological chemistry | 2011 |
Pancreatic β-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency
S Kavaler, H Morinaga, A Jih, WQ Fan, M Hedlund, A Varki, JJ Kim |
The FASEB Journal | 2011 |
Expression profiling identifies novel gene targets and functions for Pdx1 in the duodenum of mature mice
C Chen, E Sibley |
American journal of physiology. Gastrointestinal and liver physiology | 2011 |
Metabolic Syndrome
M Wang |
Metabolic Syndrome | 2011 |
Effects of chronic administration of alogliptin on the development of diabetes and β-cell function in high fat diet/streptozotocin diabetic mice
X Zhang, Z Wang, Y Huang, J Wang |
Diabetes, Obesity and Metabolism | 2011 |
Incrétines et nutrition entérale
D Quilliot, A Malgras, C Zallot, O Ziegler |
Réanimation | 2011 |
The potential of incretin-based therapies in type 1 diabetes
CS Suen, P Burn |
Drug Discovery Today | 2011 |
Blunted Insulinemia Using High Dialysate Glucose Concentration During Hemodialysis :
R Czabak-Garbacz, D Schneditz, E Zierler, E Eichmann, G Harter, H Hafner-Giessauf, B Obermayer-Pietsch |
ASAIO Journal | 2011 |
Nutrient detection by incretin hormone secreting cells
E Diakogiannaki, FM Gribble, F Reimann |
Physiology & Behavior | 2011 |
GLP-1 signaling and the regulation of pancreatic β-cells mass/function
J Buteau |
Avances en Diabetología | 2011 |
Control metabólico y pérdida de peso en pacientes con obesidad y diabetes mellitus tipo 2 tratados con exenatida
PP Alarcón, MD Gil, LM Román, MF Gómez, MV Zafra, JT Massó |
Medicina Clínica | 2011 |
Using Computer-aided Drug Design and Medicinal Chemistry Strategies in the Fight Against Diabetes
EP Semighini, JA Resende, P Andrade, PA Morais, I Carvalho, CA Taft, CH Silva |
Journal of Biomolecular Structure and Dynamics | 2011 |
The Expression and Function of Glucose-Dependent Insulinotropic Polypeptide in the Embryonic Mouse Pancreas
K Prasadan, M Koizumi, S Tulachan, C Shiota, N Lath, J Paredes, P Guo, Y El-Gohary, M Malek, S Shah, GK Gittes |
Diabetes | 2011 |
Disruption of Circadian Rhythms Accelerates Development of Diabetes through Pancreatic Beta-Cell Loss and Dysfunction
JE Gale, HI Cox, J Qian, GD Block, CS Colwell, AV Matveyenko |
Journal of Biological Rhythms | 2011 |
Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1
RO Crajoinas, FT Oricchio, TD Pessoa, BP Pacheco, LM Lessa, G Malnic, AC Girardi |
American journal of physiology. Renal physiology | 2011 |
The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
A Lund, T Vilsbøll, JI Bagger, JJ Holst, FK Knop |
American journal of physiology. Endocrinology and metabolism | 2011 |
PWD/PhJ and WSB/EiJ Mice Are Resistant to Diet-Induced Obesity But Have Abnormal Insulin Secretion
KT Lee, S Karunakaran, MM Ho, SM Clee |
Endocrinology | 2011 |
An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells
Jeffrey Sturek, David Castle, Anthony Trace, Laura Page, Anna Castle, Carmella Evans-Molina, John Parks, Raghavendra Mirmira, Catherine Hedrick |
Journal of Clinical Investigation | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2010 |
Diabetic cardiomyopathy: signaling defects and therapeutic approaches
JS Dobrin, D Lebeche |
Expert Review of Cardiovascular Therapy | 2010 |
Cholesterol in β-cell Dysfunction: The Emerging Connection Between HDL Cholesterol and Type 2 Diabetes
LR Brunham, JK Kruit, MR Hayden, CB Verchere |
Current Diabetes Reports | 2010 |
Add-on therapies to metformin for type 2 diabetes
M Shomali |
Expert Opinion on Pharmacotherapy | 2010 |
Textbook of Diabetes
PM Jones, SJ Persaud |
Textbook of Diabetes | 2010 |
Brook's Clinical Pediatric Endocrinology
M Westwood |
Brook's Clinical Pediatric Endocrinology | 2010 |
Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice
JK Kruit, PH Kremer, L Dai, R Tang, P Ruddle, W Haan, LR Brunham, CB Verchere, MR Hayden |
Diabetologia | 2010 |
Exenatide and weight loss
DP Bradley, R Kulstad, DA Schoeller |
Nutrition | 2010 |
Bariatric surgery and its impact on sleep architecture, sleep-disordered breathing, and metabolism
S Pannain, B Mokhlesi |
Best Practice & Research Clinical Endocrinology & Metabolism | 2010 |
Continuous Subcutaneous Insulin Infusion—An Historical Perspective
JS Skyler |
Diabetes Technology & Therapeutics | 2010 |
The use of exenatide in severely burned pediatric patients
GA Mecott, DN Herndon, GA Kulp, NC Brooks, AM Al-Mousawi, R Kraft, HG Rivero, FN Williams, LK Branski, MG Jeschke |
Critical Care | 2010 |
Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes
M Salehi, B Aulinger, RL Prigeon, DA D'Alessio |
Diabetes | 2010 |
Bench-to-bedside review: The gut as an endocrine organ in the critically ill
A Deane, MJ Chapman, RJ Fraser, M Horowitz |
Critical Care | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
Textbook of Diabetes: Holt/Textbook of Diabetes
HE Larsson, AJ Delli, SA Ivarsson, Å Lernmark |
Textbook of Diabetes: Holt/Textbook of Diabetes | 2010 |
A Model for Glucose, Insulin, and Beta-Cell Dynamics in Subjects With Insulin Resistance and Patients With Type 2 Diabetes
J Ribbing, B Hamrén, MK Svensson, MO Karlsson |
The Journal of Clinical Pharmacology | 2010 |
New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1)
Z Yu, T Jin |
Cellular Signalling | 2010 |
Final Answer: Ghrelin Can Suppress Insulin Secretion in Humans, but Is It Clinically Relevant?
C Meyer |
Diabetes | 2010 |
HDL: More Than Just Cholesterol
A Meilina, A Wijaya |
The Indonesian Biomedical Journal | 2010 |
A Review of Exenatide in the Treatment of Type 2 Diabetes Mellitus
AG Samat, A Bhargava, V Reddy |
Clinical medicine insights. Therapeutics | 2010 |
Targeting β-Cell Function Early in the Course of Therapy for Type 2 Diabetes Mellitus
JL Leahy, IB Hirsch, KA Peterson, D Schneider |
The Journal of clinical endocrinology and metabolism | 2010 |
Recombinant Expression, in Vitro Refolding, and Biophysical Characterization of the Human Glucagon-like Peptide-1 Receptor
K Schröder-Tittmann, E Bosse-Doenecke, S Reedtz-Runge, C Ihling, A Sinz, K Tittmann, R Rudolph |
Biochemistry | 2010 |
Successful Versus Failed Adaptation to High-Fat Diet-Induced Insulin Resistance: The Role of IAPP-Induced -Cell Endoplasmic Reticulum Stress
AV Matveyenko, T Gurlo, M Daval, AE Butler, PC Butler |
Diabetes | 2009 |
Insulin secretion in healthy subjects and patients with Type 2 diabetes – role of the gastrointestinal tract
J Ma, CK Rayner, KL Jones, M Horowitz |
Best Practice & Research Clinical Endocrinology & Metabolism | 2009 |
Surgical Approaches for the Prevention and Treatment of Type 2 Diabetes Mellitus
S Coffin, C Konduru, M Schwarcz, W Frishman |
Cardiology in Review | 2009 |
Roles of cAMP signalling in insulin granule exocytosis
S Seino, H Takahashi, W Fujimoto, T Shibasaki |
Diabetes, Obesity and Metabolism | 2009 |
The contribution of incretin hormones to the pathogenesis of type 2 diabetes
JJ Meier |
Best Practice & Research Clinical Endocrinology & Metabolism | 2009 |
Therapeutic potential for GIP receptor agonists and antagonists
N Irwin, PR Flatt |
Best Practice & Research Clinical Endocrinology & Metabolism | 2009 |
Targeting the Incretin System in Type 2 Diabetes Mellitus
M Potenza, EJ Rayfield |
Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine | 2009 |
New treatments in type 2 diabetes: a focus on the incretin-based therapies
AH Barnett |
Clinical Endocrinology | 2009 |
Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes
N Irwin, PL McClean, S Patterson, K Hunter, PR Flatt |
Biological Chemistry | 2009 |
Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors
EJ Verspohl |
Pharmacology & Therapeutics | 2009 |
A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease
EZ Fisman, A Tenenbaum |
Cardiovascular Diabetology | 2009 |
Role and development of GLP-1 receptor agonists in the management of diabetes
CW Chia, JM Egan |
Diabetes, metabolic syndrome and obesity : targets and therapy | 2009 |
Beyond Glycemic Control: Treating the Entire Type 2 Diabetes Disorder
S Brunton |
Postgraduate Medicine | 2009 |
Stimulation of incretin secretion by dietary lipid: is it dose dependent?
SM Yoder, Q Yang, TL Kindel, P Tso |
AJP Gastrointestinal and Liver Physiology | 2009 |
Cholesterol in islet dysfunction and type 2 diabetes
Liam R. Brunham, Janine K. Kruit, C. Bruce Verchere and Michael R. Hayden |
Journal of Clinical Investigation | 2008 |
Targeting β-Cell Mass in Type 2 Diabetes: Promise and Limitations of New Drugs Based on Incretins
M Salehi, BA Aulinger, DA D'Alessio |
Endocrine reviews | 2008 |
The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
W Kim, JM Egan |
Pharmacological reviews | 2008 |
Effect of Weight Loss by Gastric Bypass Surgery Versus Hypocaloric Diet on Glucose and Incretin Levels in Patients with Type 2 Diabetes
B Laferrère, J Teixeira, J McGinty, H Tran, JR Egger, A Colarusso, B Kovack, B Bawa, N Koshy, H Lee, K Yapp, B Olivan |
The Journal of clinical endocrinology and metabolism | 2008 |
Beta cell mass in diabetes: a realistic therapeutic target?
JJ Meier |
Diabetologia | 2008 |
Insulin increases excitability via a dose-dependent dual inhibition of voltage-activated K+currents in differentiated N1E-115 neuroblastoma cells
PA Lima, MI Vicente, FM Alves, JC Dionísio, PF Costa |
European Journal of Neuroscience | 2008 |
Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes
M Florentin, EN Liberopoulos, DP Mikhailidis, E MS |
Expert Opinion on Pharmacotherapy | 2008 |
DPP4 Inhibitors: a new approach in diabetes treatment
J Doupis, A Veves |
Advances in Therapy | 2008 |
Therapeutic Potential of Dipeptidyl Peptidase-IV Inhibitors in Patients With Diabetes Mellitus
KB Moore, CD Saudek |
American Journal of Therapeutics | 2008 |
Role of the incretin system in the remission of type 2 diabetes following bariatric surgery
G Mingrone |
Nutrition, Metabolism and Cardiovascular Diseases | 2008 |
Protection of pancreatic beta-cells: Is it feasible?
E Bonora |
Nutrition, Metabolism and Cardiovascular Diseases | 2008 |
Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats
AV Matveyenko, JD Veldhuis, PC Butler |
American journal of physiology. Endocrinology and metabolism | 2008 |
β-cell apoptosis in type 2 diabetes: quantitative and functional consequences
R Lupi, SD Prato |
Diabetes & Metabolism | 2008 |
Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes
C Gredal, A Rosenfalck, A Dejgaard, J Hilsted |
Diabetes Research and Clinical Practice | 2008 |
The incretins: From the concept to their use in the treatment of type 2 diabetes. Part A: Incretins: Concept and physiological functions
J Girard |
Diabetes & Metabolism | 2008 |
GLP-1 et système nerveux : un mécanisme de son action antidiabétique
R Burcelin, M Massebœuf, C Cabou |
Médecine des Maladies Métaboliques | 2008 |
Dipeptidyl Peptidase-4 as a New Target of Action for Type 2 Diabetes Mellitus: A Systematic Review
JH Wani, J John-Kalarickal, VA Fonseca |
Cardiology Clinics | 2008 |
GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis
K Toyoda, T Okitsu, S Yamane, T Uonaga, X Liu, N Harada, S Uemoto, Y Seino, N Inagaki |
Biochemical and Biophysical Research Communications | 2008 |
Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?
LF van Gaal, SW Gutkin, MA Nauck |
European Journal of Endocrinology | 2008 |
Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein
AV Matveyenko, JD Veldhuis, PC Butler |
American journal of physiology. Endocrinology and metabolism | 2008 |
Adaptation to intermittent stress promotes maintenance of β-cell compensation: comparison with food restriction
HE Bates, A Sirek, MA Kiraly, JT Yue, MC Riddell, SG Matthews, M Vranic |
American journal of physiology. Endocrinology and metabolism | 2008 |
Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and β-cell mass to age-related insulin resistance in rats
AV Matveyenko, JD Veldhuis, PC Butler |
American journal of physiology. Endocrinology and metabolism | 2008 |
Beyond Glycemic Control
CL Martin |
The Diabetes Educator | 2008 |
Controversies in Treating Diabetes
D LeRoith, AI Vinik |
2008 | |
Type 2 Diabetes Mellitus
MN Feinglos, MA Bethel |
2008 | |
Pancreatic Beta Cell in Health and Disease
S Seino, GI Bell |
2008 | |
Extrapancreatic incretin receptors modulate glucose homeostasis, body weight and energy expenditure
Tanya Hansotia, Adriano Maida, Grace Flock, Yuichiro Yamada, Katsushi Tsukiyama, Yutaka Seino, Daniel J Drucker |
Journal of Clinical Investigation | 2007 |
β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment
LR Brunham, JK Kruit, TD Pape, JM Timmins, AQ Reuwer, Z Vasanji, BJ Marsh, B Rodrigues, JD Johnson, JS Parks, CB Verchere, MR Hayden |
Nature Medicine | 2007 |
Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes
B Laferrère, S Heshka, K Wang, Y Khan, J McGinty, J Teixeira, AB Hart, B Olivan |
Diabetes care | 2007 |
Glucose-dependent insulinotropic polypeptide and its role in obesity
DH Song, MM Wolfe |
Current Opinion in Endocrinology, Diabetes and Obesity | 2007 |
Incretins and their role in the management of diabetes
JP Frias, SV Edelman |
Current Opinion in Endocrinology, Diabetes and Obesity | 2007 |
Incretin hormone mimetics and analogues in diabetes therapeutics
BD Green, PR Flatt |
Best Practice & Research Clinical Endocrinology & Metabolism | 2007 |
Efficacy and Safety of Mitiglinide in Korean Type 2 Diabetic Patients: Prospective Randomised Multicenter Comparative Phase III Study
SY Kim, HJ Kim, KA Han, SH Baek, HS Son, BS Cha, KW Min |
The Journal of Korean Diabetes Association | 2007 |
DPP-4 inhibitors as a new target of action for Type 2 diabetes mellitus: a focus on vildagliptin
V Fonseca, AD Rao |
Expert Review of Endocrinology & Metabolism | 2007 |
Metabolic Syndrome and Type 2 Diabetes: Can We Stop the Weight Gain with Diabetes?
D Joffe, RT Yanagisawa |
Medical Clinics of North America | 2007 |
Prandial Premixed Insulin Analogue Regimens Versus Basal Insulin Analogue Regimens in the Management of Type 2 Diabetes: An Evidence-Based Comparison
LL Ilag, L Kerr, JK Malone, MH Tan |
Clinical Therapeutics | 2007 |
Gut hormones, incretin mimetics and gliptins: New understanding and novel therapies in type 2 diabetes
NM Munro, JC Levy |
Primary Care Diabetes | 2007 |
A triumph for physiology driving drug discovery: the potential impact of dipeptidyl peptidase-IV inhibitors in type 2 diabetes
R Donnelly |
Diabetes, Obesity and Metabolism | 2007 |
Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug
I Idris, R Donnelly |
Diabetes, Obesity and Metabolism | 2007 |
A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies
A Barnett, J Allsworth, K Jameson, R Mann |
Current Medical Research and Opinion | 2007 |
Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects
JJ Meier, CF Deacon, WE Schmidt, JJ Holst, MA Nauck |
Diabetologia | 2007 |
Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes
D Maggs, I MacDonald, MA Nauck |
Diabetes, Obesity and Metabolism | 2007 |
A Mathematical Model of the Oral Glucose Tolerance Test Illustrating the Effects of the Incretins
PL Brubaker, EL Ohayon, LM D’Alessandro, KH Norwich |
Annals of Biomedical Engineering | 2007 |
Polycystic Ovary Syndrome
MA Brown, RJ Chang |
Ultrasound Quarterly | 2007 |
Early-phase insulin secretion is disturbed in obese subjects with glucose intolerance
A Mizuno, H Arai, M Fukaya, M Sato, YO Hisami, E Takeda, T Doi |
Metabolism | 2007 |
Metabolic Syndrome and Cardiovascular Disease: Epidemiology, Assessment, and Management
S Wild, C Byrne |
Metabolic Syndrome and Cardiovascular Disease: Epidemiology, Assessment, and Management | 2007 |
An Integrated Glucose-Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics
PM Jauslin, HE Silber, N Frey, R Gieschke, US Simonsson, K Jorga, MO Karlsson |
The Journal of Clinical Pharmacology | 2007 |
Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients
E Muscelli, A Mari, A Casolaro, S Camastra, G Seghieri, A Gastaldelli, JJ Holst, E Ferrannini |
Diabetes | 2007 |
Insulin Sensitivity as a Risk Factor for Common Carotid Intima Media Thickness (IMT): Its Relation to Atherosclerosis
SS Deo, SR Mahadik, AR Chogle, SL Soneji, CP Lulla |
Clinical and Experimental Hypertension | 2007 |
The Physiology of Glucagon-like Peptide 1
JJ Holst |
Physiological reviews | 2007 |
New drugs for the treatment of type 2 diabetes
TA Chowdhury, B Hossain |
BRIT J HOSP MED | 2007 |
Asthma and Hyperglycemia
S Chawla, D Seth, J Cortez, P Mahajan, D Kamat |
Clinical Pediatrics | 2007 |
Pharmacotherapy of Diabetes: New Developments
CE Mogensen |
2007 | |
Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects
JJ Meier, C F., WE Schmidt, JJ Holst, MA Nauck |
Diabetologia | 2007 |
-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes
AV Matveyenko, PC Butler |
Diabetes | 2006 |
GLP-1 et détection cérébrale du glucose, un relais de régulation de l’homéostasie glucidique
R Burcelin, PD Cani, C Knauf |
médecine/sciences | 2006 |
Dipeptidyl Aminopeptidases
U Lendeckel, D Reinhold, U Bank |
2006 | |
Dipeptidyl Aminopeptidases
U Lendeckel, D Reinhold, U Bank |
2006 | |
Dipeptidyl Aminopeptidases
U Lendeckel, D Reinhold, U Bank |
2006 | |
Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level
C Alarcon, B Wicksteed, CJ Rhodes |
Diabetologia | 2006 |
Incretins and the development of type 2 diabetes
JJ Meier, MA Nauck |
Current Diabetes Reports | 2006 |
Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: Potential New Therapies for Type 2 Diabetes Mellitus
C Triplitt, A Wright, E Chiquette |
Pharmacotherapy | 2006 |
Exenatide: A Novel Approach for Treatment of Type 2 Diabetes
N Mikhail |
Southern Medical Journal | 2006 |
Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: A Review of Emerging Therapies for Type 2 Diabetes
DM Kendall, D Kim, D Maggs |
Diabetes Technology & Therapeutics | 2006 |
Exenatide: first-in-class incretin mimetic for the treatment of Type 2 diabetes mellitus
C Triplitt, RA DeFronzo |
Expert Review of Endocrinology & Metabolism | 2006 |
Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes
CA Schnabel, M Wintle, O Kolterman |
Vascular Health and Risk Management | 2006 |
DPP-4 inhibitors and their potential role in the management of type 2 diabetes
A Barnett |
International Journal of Clinical Practice | 2006 |
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans
J Schirra, M Nicolaus, R Roggel, M Katschinski, M Storr, HJ Woerle, B Göke |
Gut | 2006 |
Glycaemic management of type 2 diabetes
M Davies, B Srinivasan |
Medicine | 2006 |
Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin
T Adachi, T Tanaka, K Takemoto, T Koshimizu, A Hirasawa, G Tsujimoto |
Biochemical and Biophysical Research Communications | 2006 |
Chronic Pancreatitis: Recent Advances and Ongoing Challenges
SA Ahmad, CJ Wray, HR Rilo, KA Choe, A Gelrud, J Howington, AM Lowry, JB Matthews |
Current Problems in Surgery | 2006 |
Upper gastrointestinal function and glycemic control in diabetes mellitus
R Chaikomin, CK Rayner, KL Jones, M Horowitz |
World journal of gastroenterology : WJG | 2006 |
Pancreatic and Extrapancreatic Effects of Gastric Inhibitory Polypeptide
Y Yamada, K Miyawaki, K Tsukiyama, N Harada, C Yamada, Y Seino |
Diabetes | 2006 |
Emerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1
MC Riddle, DJ Drucker |
Diabetes care | 2006 |
Molekularmedizinische Grundlagen von para- und autokrinen Regulationsstörungen
D Ganten, K Ruckpaul, J Köhrle |
2006 | |
New Insights into Glucose Regulation
DF Kruger, CL Martin, CE Sadler |
The Diabetes Educator | 2006 |
Ispol'zovanie inkretinov v lecheniisakharnogo diabeta 2 tipa - vcherashnyaya mechta,blizkaya k real'nosti segodnya
AM Mkrtumyan, EV Biryukova |
Diabetes mellitus | 2006 |
The incretins: a link between nutrients and well-being
R Burcelin |
British Journal of Nutrition | 2005 |
The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management
OA Roges, M Baron, A Philis-Tsimikas |
Expert Opinion on Investigational Drugs | 2005 |
Islet adaptation to insulin resistance: mechanisms and implications for intervention
B Ahren, G Pacini |
Diabetes, Obesity and Metabolism | 2005 |
Glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase IV inhibitors: new therapeutic agents for the treatment of type 2 diabetes
EM Sinclair, DJ Drucker |
Current Opinion in Endocrinology & Diabetes | 2005 |
Glucagon-like peptide 1(GLP-1) in biology and pathology
JJ Meier, MA Nauck |
Diabetes/Metabolism Research and Reviews | 2005 |
α-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients
K Hücking, Z Kostic, C Pox, R Ritzel, JJ Holst, W Schmiegel, MA Nauck |
Diabetic Medicine | 2005 |
The GLP‐1 system as a therapeutic target
MC Edwards |
Annals of Medicine | 2005 |
Gastrointestinal Physiology
WC Orr |
Principles and Practice of Sleep Medicine | 2005 |
The [pre-] history of the incretin concept
W Creutzfeldt |
Regulatory Peptides | 2005 |
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
T Hansotia, DJ Drucker |
Regulatory Peptides | 2005 |
Pioglitazone prevents reactive hypoglycemia in impaired glucose tolerance
K Arii, K Ota, T Suehiro, Y Ikeda, K Nishimura, Y Kumon, K Hashimoto |
Diabetes Research and Clinical Practice | 2005 |
Pathogenesis of Type 2 Diabetes Mellitus
JL Leahy |
Archives of Medical Research | 2005 |
PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
S Seino, T Shibasaki |
Physiological reviews | 2005 |
The incretin mimetic, exenatide: a novel treatment option for type 2 diabetes
CA Schnabel |
The British Journal of Diabetes & Vascular Disease | 2005 |
Loss of beta cell function as fasting glucose increases in the non-diabetic range
IF Godsland, JA Jeffs, DG Johnston |
Diabetologia | 2004 |
Restoration of early insulin secretion after a meal in type 2 diabetes: effects on lipid and glucose metabolism
G Dimitriadis, E Boutati, V Lambadiari, P Mitrou, E Maratou, P Brunel, SA Raptis |
European Journal of Clinical Investigation | 2004 |
Can we make surrogate β-cells better than the original?
GC Weir |
Seminars in Cell & Developmental Biology | 2004 |
Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes
MA Nauck, A El-Ouaghlidi, B Gabrys, K Hücking, JJ Holst, CF Deacon, B Gallwitz, WE Schmidt, JJ Meier |
Regulatory Peptides | 2004 |
Factor analysis of the metabolic syndrome in spinal cord-injured men
LM Jones, M Legge, A Goulding |
Metabolism | 2004 |
Gastro-intestinal hormones GIP and GLP-1
TJ Kieffer |
Annales d'Endocrinologie | 2004 |
Incretins, insulin secretion and Type 2 diabetes mellitus
T Vilsbøll, JJ Holst |
Diabetologia | 2004 |
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
A Caumo, L Luzi |
American journal of physiology. Endocrinology and metabolism | 2004 |
Avaliação dietética de amidos pelas respostas glicêmica e insulinêmica em cães
GB Silveira, BP Paule, EP Socorro |
ARQ BRAS MED VET ZOO | 2004 |
Splanchnic bed metabolism of glucose in preterm neonates
SR van der Schoor, B Stoll, DL Wattimena, HA Büller, D Tibboel, DG Burrin, JB van Goudoever |
The American journal of clinical nutrition | 2004 |
Dipeptidyl Aminopeptidases in Health and Disease
N Back, IR Cohen, D Kritchevsky, A Lajtha, R Paoletti |
2004 | |
International Textbook of Diabetes Mellitus
RA DeFronzo, L Mandarino, E Ferrannini |
International Textbook of Diabetes Mellitus | 2003 |
Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?
VA Gault, FP O’Harte, PR Flatt |
Neuropeptides | 2003 |
Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus
JE Gerich |
Mayo Clinic Proceedings | 2003 |
Hepatic glucose metabolism in humans—its role in health and disease
M Roden, E Bernroider |
Best Practice & Research Clinical Endocrinology & Metabolism | 2003 |
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study
A Gastaldelli, E Ferrannini, Y Miyazaki, M Matsuda, RA DeFronzo, |
Diabetologia | 2003 |
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
SE Kahn |
Diabetologia | 2003 |
Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect
RL Prigeon, S Quddusi, B Paty, DA D'Alessio |
American journal of physiology. Endocrinology and metabolism | 2003 |
Engineering physiologically regulated insulin secretion in non-β cells by expressing glucagon-like peptide 1 receptor
L Wu, W Nicholson, CY Wu, M Xu, A McGaha, M Shiota, AC Powers |
Gene Therapy | 2003 |
Effect of Motilin on Endogenous Release of Insulin in Conscious Dogs in the Fed State
H Suzuki, H Kuwano, E Mochiki, N Haga, T Shimura, K Nomoto, T Tanaka, A Mizumoto, Z Itoh |
Digestive Diseases and Sciences | 2003 |
Differential effects of hyperlipidemia on insulin secretion in islets of langerhans from hyperglycemic versus normoglycemic rats
I Briaud, CL Kelpe, LM Johnson, PO Tran, V Poitout |
Diabetes | 2002 |
Insulin analogues: New therapies for type 2 diabetes mellitus
MA Bethel, MN Feinglos |
Current Diabetes Reports | 2002 |
The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes
RN Bergman, DT Finegood, SE Kahn |
European Journal of Clinical Investigation | 2002 |
Das Inkretinhormon GLP-1: Eine therapeutische Option bei Typ-2-Diabetes?
B Göke, B Hoppe, A Konrad, J Schirra |
Pharmazie in unserer Zeit | 2002 |
Insulin Therapy
R Ritzel, P Butler |
Insulin Therapy | 2002 |
Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis
J Radziuk, S Pye |
Diabetes/Metabolism Research and Reviews | 2001 |
Incretin hormones - an update
JJ Ørskov |
Scandinavian Journal of Clinical & Laboratory Investigation | 2001 |
Metabolic handling of intraduodenal vs. intravenous glucose in humans
F Féry, J Devière, EO Balasse |
American journal of physiology. Endocrinology and metabolism | 2001 |
Obesity, Body Fat Distribution, Insulin Sensitivity and Islet β-Cell Function as Explanations for Metabolic Diversity
SE Kahn, RL Prigeon, RS Schwartz, WY Fujimoto, RH Knopp, JD Brunzell, D Porte |
The Journal of nutrition | 2001 |
Genetics of Diabetes Mellitus
WL Lowe |
2001 | |
The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes
SE Kahn |
The Journal of clinical endocrinology and metabolism | 2001 |
Streptozotocin and Alloxan in Experimental Diabetes. Comparison of the Two Models in Rats
S Islas-Andrade, MC Monsalve, JE de la Peña, AC Polanco, MA Palomino, AF Velasco |
ACTA HISTOCHEMICA ET CYTOCHEMICA | 2000 |
Possible effects of one week vitamin K (menaquinone-4) tablets intake on glucose tolerance in healthy young male volunteers with different descarboxy prothrombin levels
N SAKAMOTO, T NISHIIKE, H IGUCHI, K SAKAMOTO |
Clinical Nutrition | 2000 |
Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+signalling and insulin secretion due to blockade of L-type Ca2+channels in rat islet β-cells
T Yada, M Nakata, T Shiraishi, M Kakei |
British Journal of Pharmacology | 1999 |
GIF biology and fat metabolism
RG Yip, MM Wolfe |
Life Sciences | 1999 |
Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits
M Shiomi, T Ito, T Tsukada, Y Tsujita, H Horikoshi |
Atherosclerosis | 1999 |
Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes
M Hiroyoshi, K Tateishi, Y Yasunami, K Maeshiro, J Ono, Y Matsuoka, S Ikeda |
The American Journal of Gastroenterology | 1999 |
Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice
K Miyawaki, Y Yamada, H Yano, H Niwa, N Ban, Y Ihara, A Kubota, S Fujimoto, M Kajikawa, A Kuroe, K Tsuda, H Hashimoto, T Yamashita, T Jomori, F Tashiro, J Miyazaki, Y Seino |
Proceedings of the National Academy of Sciences | 1999 |
JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats
T Ohta, N Furukawa, F Yonemori, K Wakitani |
European Journal of Pharmacology | 1999 |
Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice
K Miyawaki, Y Yamada, H Yano, H Niwa, N Ban, Y Ihara, A Kubota, S Fujimoto, M Kajikawa, A Kuroe, K Tsuda, H Hashimoto, T Yamashita, T Jomori, F Tashiro, J Miyazaki, Y Seino |
Proceedings of the National Academy of Sciences | 1999 |
Preservation of the incretin effect after orthotopic pancreas transplantation in inbred rats
HJ Kissler, H Gepp, A Schmiedl, PO Schwille |
Metabolism | 1999 |
The Glucagon-Like Peptides
TJ Kieffer, JF Habener |
Endocrine reviews | 1999 |
Implications of blood glucose, insulin resistance and β-cell function in impaired glucose tolerance
B Göke |
Diabetes Research and Clinical Practice | 1998 |
The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity
JE Gerich |
Endocrine reviews | 1998 |
Glucagon-Like-Peptide-1 Secretion from Canine L-Cells Is Increased by Glucose-Dependent-Insulinotropic Peptide but Unaffected by Glucose
AB Damholt, AM Buchan, H Kofod |
Endocrinology | 1998 |
Quantification of the effects of troglitazone on insulin sensitivity and β-cell function in Watanabe heritable hyperlipidemic rabbits: A minimal model analysis
B Zhang, K Saku, K Arakawa |
Metabolism | 1997 |
Incretin hormone expression in the gut of diabetic mice and rats
P Berghöfer, RG Peterson, K Schneider, HC Fehmann, B Göke |
Metabolism | 1997 |
7 Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus
DA Ehrmann |
Baillière's Clinical Obstetrics and Gynaecology | 1997 |
Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM
O Schmitz, N Porksen, B Nyholm, C Skjaerbaek, PC Butler, JD Veldhuis, SM Pincus |
American journal of physiology. Endocrinology and metabolism | 1997 |
Clinical Research in Diabetes and Obesity
B Draznin, R Rizza |
1997 | |
Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons
DA D'Alessio, R Vogel, R Prigeon, E Laschansky, D Koerker, J Eng, JW Ensinck |
Journal of Clinical Investigation | 1996 |
AN INTEGRATED VIEW OF β-CELL DYSFUNCTION IN TYPE-II DIABETES
VP Ph.D, RP M.D |
Annual Review of Medicine | 1996 |
Insulin-Stimulated Glucose Disposal: Does Adipose Play a Role?
SC Frost |
Nutrition Reviews | 1996 |
Vergleich pyloruserhaltende Whippel-Operation mit duodenumerhaltender Pankreaskopfresektion
MW Büchler, D Lübke, MW Müller, H Friess |
European Surgery | 1996 |
Regulation of glucagon-like peptide-I receptor expression and transcription by the protein kinase C pathway
HC Fehmann, J Schweinfurth, J Jiang, B Göke |
Research in Experimental Medicine | 1996 |
Glucagon III
PJ Lefèbvre |
1996 | |
The relationship between insulin resistance and insulin secretion in japanese subjects with borderline glucose intolerance
T Wasada |
Diabetes Research and Clinical Practice | 1995 |
NIDDM in the Cat: Treatment with the Oral Hypoglycemic Medication, Glipizide
SL Ford |
Veterinary Clinics of North America Small Animal Practice | 1995 |
Intestinal effects of α-glucosidase inhibitors: absorption of nutrients and enterohormonal changes
B Göke, C Herrmann, R Göke, HC Fehmann, P Berghöfer, G Richter, R Arnold |
European Journal of Clinical Investigation | 1994 |
A glimpse of the ‘natural history’ of established Type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis
PA Coates, RL Ollerton, SD Luzio, I Ismail, DR Owens |
Diabetes Research and Clinical Practice | 1994 |
Hyperinsulinemia in glucose intolerance: Is it true?
D Giugliano, A Quatraro, R Acampora, ND Rosa, A Ceriello, F D’Onofrio |
Journal of Endocrinological Investigation | 1994 |
Aberrant Function and Long-Term Survival of Mouse β Cells Exposed In Vitro to High Glucose Concentrations
M Pehuet-Figoni, E Ballot, JF Bach, L Chatenoud |
Cell Transplantation | 1994 |
Molecular Biology of Diabetes
B Draznin, D LeRoith |
1994 | |
Physiologic relevance of heterogeneity in the pancreatic beta-cell population
D Pipeleers, R Kiekens, Z Ling, A Wilikens, F Schuit |
Diabetologia | 1994 |
Hyperinsulinemia in glucose intolerance: Is it true?
D Giugliano, A Quatraro, R Acampora, ND Rosa, A Ceriello, F DOnofrio |
Journal of Endocrinological Investigation | 1994 |
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
MA Nauck, MM Heimesaat, C Orskov, JJ Holst, R Ebert, W Creutzfeldt |
Journal of Clinical Investigation | 1993 |
Glucokinase and candidate genes for Type 2 (non-insulin-dependent) diabetes mellitus
PJ Randle |
Diabetologia | 1993 |
Hormonal responses and future treatment of non-insulin-dependent diabetes mellitus (NIDDM)
S Efendic, CG Östenson |
Journal of Internal Medicine | 1993 |
Glucokinase activity in isolated islets from obese fa/fa Zucker rats
CB Chan |
Biochemical Journal | 1993 |
Hepatic extraction of insulin after stimulation of secretion with oral glucose or parenteral nutrients
J Dupré, MT Behme, IM Hramiak, CJ Longo |
Metabolism | 1993 |
Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis
CN Hales, DJ Barker |
Diabetologia | 1992 |
Gut hormones and diabetes mellitus
W Creutzfeldt, M Nauck |
Diabetes / Metabolism Reviews | 1992 |
Type II Diabetes: Search for Primary Defects
R Turner, A Hattersley, J Cook |
Annals of Medicine | 1992 |
Glucagon-like peptide-1(7–37)/(7–36)amide is a new incretin
HC Fehmann, R Göke, B Göke |
Molecular and Cellular Endocrinology | 1992 |
Beta-cell secretory defect caused by mutations in glucokinase gene
R Page, A Hattersley, R Turner, G Velho, K Clément, ME Pueyo, P Froguel |
The Lancet | 1992 |
Role of Reduced Suppression of Glucose Production and Diminished Early Insulin Release in Impaired Glucose Tolerance
A Mitrakou, D Kelley, M Mokan, T Veneman, T Pangburn, J Reilly, J Gerich |
New England Journal of Medicine | 1992 |
Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis
YT Kruszynska, PD Home, N McIntyre |
Hepatology | 1991 |
In vitro stimulation of glucose utilization by insulin in primary cultures of rat hepatocytes
M Suzuki, H Kojima, T Nakano, A Kashiwagi, H Hidaka, K Kosugi, Y Shigeta, Y Harano |
Diabetes Research and Clinical Practice | 1991 |
Hepatic sensitivity to insulin: Effects of sulfonylurea drugs
SD Prato, SV de Kreutzenberg, A Riccio, A Tiengo |
The American Journal of Medicine | 1991 |
Proceedings of the 1990 Laurentian Hormone Conference
AE Boyd, L Aguilar-Bryan, J Bryan, DL Kunze, L Moss, DA Nelson, AS Rajan, H Raef, H Xiang, GC Yaney |
Proceedings of the 1990 Laurentian Hormone Conference | 1991 |
The Liver and Glycogen Metabolism
J Radziuk |
JPEN. Journal of parenteral and enteral nutrition | 1991 |
Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level
JL Leahy, GC Weir |
Diabetologia | 1991 |
Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM
K Ratheiser, W Reitgruber, M Komjati, P Bratusch-Marrain, H Vierhapper, WK Waldhäusl |
Acta Diabetologica Latina | 1990 |
The Metabolic Associations of Intravenous Glucose Tolerance in the 10 Years from Diagnosis of Type 2 Diabetes
SW Coppack, CS Yajnik, HA Doll, V Thursfield, TD Hockaday |
Diabetic Medicine | 1990 |
An Unbiased Glucose Clamp Method Using a Variable Insulin Infusion: Its Application in Diabetic Adolescents
DR Matthews, JA Edge, DB Dunger |
Diabetic Medicine | 1990 |
Insulin release and peripheral sensitivity at the oral glucose tolerance test
J Cederholm, L Wibell |
Diabetes Research and Clinical Practice | 1990 |
Impaired glucose tolerance and diabetes in obesity: A 6-year follow-up study of glucose metabolism
D Jallut, A Golay, R Munger, P Frascarolo, Y Schutz, E Jéquier, JP Felber |
Metabolism | 1990 |
The influence of body weight, age and glucose tolerance on the relationship between GIP secretion and beta-cell function in man
PH Groop |
Scandinavian Journal of Clinical & Laboratory Investigation | 1989 |
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake
RA DeFronzo, E Ferrannini, DC Simonson |
Metabolism | 1989 |
Oral Hypoglycemic Agents
JA Oates, AJ Wood, JE Gerich |
New England Journal of Medicine | 1989 |
Suppression of Insulin Secretion by Falling Plasma Glucose Levels is Impaired in Type 2 Diabetes
JP Hosker, MA Burnett, DR Matthews, RC Turner |
Diabetic Medicine | 1988 |
Metabolic basis of obesity and noninsulin-dependent diabetes mellitus
A Golay, JP Felber, E Jequier, RA DeFronzo, E Ferrannini |
Diabetes / Metabolism Reviews | 1988 |
Secretion uncouples glucose inhibition of glucagon-producing cells resulting in a simultaneous stimulation of both glucagon and insulin release
H Kofod, JJ Holst, Å Lernmark |
Regulatory Peptides | 1988 |
2 Role of insulin resistance in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus
JE Gerich |
Baillière's Clinical Endocrinology and Metabolism | 1988 |
Potential Incretins
LT Shuster, VL Go, RA Rizza, PC O'brien, FJ Service |
Mayo Clinic Proceedings | 1988 |
5 Enteroinsular axis
JC Brown |
Baillière's Clinical Endocrinology and Metabolism | 1988 |
3 Pathogenesis of NIDDM—a disease of deficient insulin secretion
RC Turner, DR Matthews, A Clark, S O'Rahilly, AS Rudenski, J Levy |
Baillière's Clinical Endocrinology and Metabolism | 1988 |
The Pathology of the Endocrine Pancreas in Diabetes
PJ Lefèbvre, DG Pipeleers |
1988 | |
Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes
JF Caro, MK Sinha, SM Raju, O Ittoop, WJ Pories, EG Flickinger, D Meelheim, GL Dohm |
Journal of Clinical Investigation | 1987 |
Plasma amino acid values and pancreatic β-cell function in phenylketonuria
I Antonozzi, C Carducci, L Vestri, V Manzari, R Dominici |
Journal of Inherited Metabolic Disease | 1987 |
Gastrointestinal peptides and insulin secretion
R Ebert, W Creutzfeldt |
Diabetes / Metabolism Reviews | 1987 |
Tracer methods and the metabolic disposal of a carbohydrate load in man
J Radziuk |
Diabetes / Metabolism Reviews | 1987 |
Regulation of hepatic glucose metabolism in humans
RA DeFronzo, E Ferrannini |
Diabetes / Metabolism Reviews | 1987 |
Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line
DJ Drucker, J Philippe, S Mojsov, WL Chick, JF Habener |
Proceedings of the National Academy of Sciences | 1987 |
Metabolic factors in the insulin resistance in human obesity
M Meylan, C Henny, E Temler, E Jéquier, JP Felber |
Metabolism | 1987 |
7 Indirect calorimetry
E Jéquier, JP Felber |
Baillière's Clinical Endocrinology and Metabolism | 1987 |
Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity
JF Caro, O Ittoop, WJ Pories, D Meelheim, EG Flickinger, F Thomas, M Jenquin, JF Silverman, PG Khazanie, MK Sinha |
Journal of Clinical Investigation | 1986 |
Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes
M Nauck, F Stöckmann, R Ebert, W Creutzfeldt |
Diabetologia | 1986 |
Clinical aspects of islet B-cell function in non-insulin-dependent diabetes mellitus
WK Ward, JC Beard, D Porte |
Diabetes / Metabolism Reviews | 1986 |
Heterogeneity of insulin secretion in type II diabetes
SS Fajans |
Diabetes / Metabolism Reviews | 1986 |
α-GLUCOSIDASE INHIBITION IN OBESITY
T William-Olsson |
Acta Medica Scandinavica | 1986 |
Evaluation of insulin secretion after pancreas autotransplantation by oral or intravenous glucose challenge
P Calhoun, KS Brown, DA Krusch, E Barido, AH Farris, WG 3rd, LE Rudolf, DK Andersen, JB Hanks |
Annals of Surgery | 1986 |
Long term postnatal development of insulin secretion in early premature infants
RA King, RM Smith, GW Dahlenburg |
Early Human Development | 1986 |
Effect of a Purified Amylase Inhibitor on Carbohydrate Tolerance in Normal Subjects and Patients With Diabetes Mellitus
P Layer, RA Rizza, AR Zinsmeister, GL Carlson, EU DiMAGNO |
Mayo Clinic Proceedings | 1986 |
Gastric inhibitory polypeptide and insulin response to increasing doses of oral glucose: Dependency on glucose amount and volume of the test drink
S Schleser, R Ebert, W Creutzfeldt |
Metabolism | 1986 |
Metabolic abnormalities in children of non-insulin dependent diabetics
RD Leslie, HP Volkmann, M Poncher, I Hanning, H Orskov, KG Alberti |
British medical journal (Clinical research ed.) | 1986 |
Pathogenesis and Treatment of Diabetes Mellitus
JK Radder, HH Lemkes, HM Krans |
1986 | |
Clinical Endocrinology
A Labhart |
Clinical Endocrinology | 1986 |
Frontiers in Peritoneal Dialysis
JF Maher, JF Winchester |
1986 | |
Metabolic abnormalities in children of non-insulin dependent diabetics.
O'Rahilly SP, Matthews DR, Hosker JP, Turner RC |
BMJ | 1986 |
Effects of Previous Intake of Glucose on Postprandial Hyperglycemia in Type 2 Diabetics
V Grill, U Adamson, M Viklund |
Acta Medica Scandinavica | 1985 |
BETA BLOCKERS, BLOOD SUGARS, AND THIAZIDES
I Gove, MJ Kendall, S O'Rahilly |
The Lancet | 1985 |
Hepatic and extrahepatic splanchnic glucose metabolism in the postabsorptive and glucose fed dog
EJ Barrett, E Ferrannini, R Gusberg, S Bevilacqua, RA DeFronzo |
Metabolism | 1985 |
Glucose infused through the portal vein enhances liver gluconeogenesis and glycogenesis from [3-14C]pyruvate in the starved rat
M Soley, R Chieri, M Llobera, E Herrera |
International Journal of Biochemistry | 1985 |
A la recherche du temps perdu — epilogue to the Minkowski award lecture 1974
E Cerasi |
Diabetologia | 1985 |
New developments in the incretin concept
W Creutzfeldt, R Ebert |
Diabetologia | 1985 |
Effect of Intravenously Infused Porcine Gip on Serum Insulin in Obese and Lean Subjects Studied with the Hyperglycemic Clamp Technique
PF Amland, R Jorde, P Burhol, KE Giercksky |
Scandinavian Journal of Gastroenterology | 1985 |
Age and the Endocrine System
RH Noth, EL Mazzaferri |
Clinics in Geriatric Medicine | 1985 |
Comparison of Type I and Type II Diabetes
M Vranic, CH Hollenberg, G Steiner |
1985 | |
Influence of hyperglycemia on insulin's in vivo effects in type II diabetes
RR Revers, R Fink, J Griffin, JM Olefsky, OG Kolterman |
Journal of Clinical Investigation | 1984 |
Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroen
GB Bolli, E Tsalikian, MW Haymond, PE Cryer, JE Gerich |
Journal of Clinical Investigation | 1984 |
Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy
G Pehling, P Tessari, JE Gerich, MW Haymond, FJ Service, RA Rizza |
Journal of Clinical Investigation | 1984 |
The relative contribution of the nervous system, hormones, and metabolites to the total insulin response during a meal in the rat
HR Berthoud |
Metabolism | 1984 |
Metabolic effects of oral glucose in the liver of fasted rats
CB Niewoehner, DP Gilboe, FQ Nuttall |
American journal of physiology. Endocrinology and metabolism | 1984 |
Gastroentero-Pancreatic Hormones in Pregnancy
PJ Hornnes |
Scandinavian Journal of Gastroenterology | 1984 |
Mechanisms of Gastrointestinal Motility and Secretion
A Bennett, G Velo |
1984 | |
Evidence for restoration of hepatic glucose processing in type I diabetes mellitus
TT Aoki, FV Vlachokosta, MC Foss, MT Meistas |
Journal of Clinical Investigation | 1983 |
The 75-g oral glucose tolerance test: Effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man
WK Waldhäusl, S Gasić, P Bratusch-Marrain, P Nowotny |
Diabetologia | 1983 |
Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man
DL Sarson, PG Kopelman, HS Besterman, TR Pilkington, SR Bloom |
Diabetologia | 1983 |
The expanding clinical use of C-peptide radioimmunoassay
M Rendell |
Acta Diabetologica Latina | 1983 |
New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus
RA Defronzo, E Ferrannini, V Koivisto |
The American Journal of Medicine | 1983 |
Extrapancreatic effects of sulfonylureas
DH Lockwood, BL Maloff, SM Nowak, ML McCaleb |
The American Journal of Medicine | 1983 |
Cellular alterations responsible for insulin resistance in obesity and type II diabetes mellitus
DH Lockwood, JM Amatruda |
The American Journal of Medicine | 1983 |
Role of environmental factors in the development of noninsulin-dependent diabetes mellitus
ES Horton |
The American Journal of Medicine | 1983 |
Roles of site and timing of the morning insulin injection in type 1 diabetes
MF Witt, NH White, JV Santiago |
The Journal of Pediatrics | 1983 |
Islet-Cell Antibodies and Beta-Cell Function in Monozygotic Triplets and Twins Initially Discordant for Type I Diabetes Mellitus
S Srikanta, OP Ganda, GS Eisenbarth, JS Soeldner |
New England Journal of Medicine | 1983 |
Secretion and Hepatic Extraction of Insulin in Nondiabetic, Obese, Aged Subjects
E Bonora, C Coscelli, U Butturini |
Journal of the American Geriatrics Society | 1983 |
GIP and Insulin Responses to a Test Meal in Healthy and Obese Subjects
R Jorde, PF Amland, PG Burhol, KE Giercksky, R Ebert |
Scandinavian Journal of Gastroenterology | 1983 |
Postprandial hypoglycemia after Nissen fundoplication for reflux esophagitis
GP Zaloga, B Chernow |
Gastroenterology | 1983 |
Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus
W Waldhäusl, P Bratusch-Marrain, S Gasić, A Korn, P Nowotny |
Diabetologia | 1982 |
Clinical aspects of GIP secretion
B Beck, C Villaume, G Debry |
Acta Diabetologica Latina | 1982 |
Familial partial lipodystrophy: Complications of obesity in the non-obese?
DC Robbins, ES Horton, O Tulp, EA Sims |
Metabolism | 1982 |
Relationship between glucose oxidation and glucose tolerance in man
J Rousselle, A Bückert, P Pahud, E Jéquier, JP Felber |
Metabolism | 1982 |
Increased binding of insulin to mononuclear blood cells following gastric bypass for morbid obesity
JL Kramer, JD Halverson, L Thomas, JV Santiago |
Journal of Surgical Research | 1982 |
The Role of Carbohydrates in Appetite, Hunger and Obesity
PJ Geiselman, D Novin |
Appetite | 1982 |
Insulin secretory response to oral glucose load, diabetic microangiopathy and diabetic control: A study in non-insulin dependent diabetics
F Maneschi, J Cassar, C Lowy, EM Kohner |
Metabolism | 1982 |
The effect of hyperglycemia, hyperinsulinemia, and route of glucose administration on glucose oxidation and glucose storage
E Jacot, RA Defronzo, E Jéquier, E Maeder, JP Felber |
Metabolism | 1982 |
Effect of various oral glucose doses on plasma neutral amino acid levels
RM Pan, C Mauron, B Glaeser, RJ Wurtman |
Metabolism | 1982 |
Classification and Diagnosis of Diabetes Mellitus
S Genuth |
Medical Clinics of North America | 1982 |
Mechanisms of insulin resistance in man
RA Rizza, LJ Mandarino, JE Gerich |
The American Journal of Medicine | 1981 |
Effect of a 3-day fast on glucose storage and oxidation in obese hyperinsulinemic diabetics
JP Felber, HU Meyer, B Curchod, E Maeder, P Pahud, E Jéquier |
Metabolism | 1981 |
Glucose storage and oxidation in different degrees of human obesity measured by continuous indirect calorimetry
JP Felber, HU Meyer, B Curchod, HU Iselin, J Rousselle, E Maeder, P Pahud, E Jéquier |
Diabetologia | 1981 |
Exacerbation of Diabetes Mellitus by Antibodies to Exogenous Insulin
M Rendell, RG Hamilton, HM Drew, NF Adkinson |
The American Journal of the Medical Sciences | 1981 |
Enteral Nutritional Therapy
JL Rombeau, LR Barot |
Surgical Clinics of North America | 1981 |
Dose-response characteristics for effects of insulin on production and utilization of glucose in man
RA Rizza, LJ Mandarino, JE Gerich |
American journal of physiology. Endocrinology and metabolism | 1981 |
Glucose storage and oxidation in different degrees of human obesity measured by continuous indirect calorimetry
, HU Meyer, B Curchod, HU Iselin, J Rousselle, E Maeder, P Pahud, E Jéquier |
Diabetologia | 1981 |
The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity
RJ Mahler |
Acta Diabetologica | 1981 |
Status of pancreatic transplants and mechanical devices for blood glucose control in diabetes
JV Santiago, NH White |
Annals of Biomedical Engineering | 1980 |
Carbohydrate Homeostasis and the Liver
J Wahren |
Acta Medica Scandinavica | 1980 |
DEVELOPMENTAL ASPECTS OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) AND ITS POSSIBLE ROLE IN THE ENTEROINSULAR AXIS IN NEONATES
A Lucas, DL Sarson, SR Bloom, A Aynsley-Green |
Acta Paediatrica | 1980 |
THE EFFECT OF INCREASING DOSES OF INGESTED GLUCOSE ON INSULIN AND GASTRIC INHIBITORY POLYPEPTIDE (GIP) CONCENTRATIONS IN MAN
JM Falko, SE Crockett, S Cataland, TM O'dorisio, W Kramer, EL Mazzaferri |
Clinical Endocrinology | 1980 |
Invited commentary
PJ Kozinn |
World Journal of Surgery | 1980 |
The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man
E Ferrannini, J Wahren, P Felig, RA DeFronzo |
Metabolism | 1980 |
Oral glucose tolerance test: Effect of different glucose loads on splanchnic carbohydrate and substrate metabolism in healthy man
PR Bratusch-Marrain, WK Waldhäusl, S Gasić, A Korn, P Nowotny |
Metabolism | 1980 |
Cholecystokinin and gastric inhibitory polypeptide not glucagonotropic in dogs
KR Sirinek, BA Levine, SE Crockett, S Cataland |
Journal of Surgical Research | 1980 |
Therapy of insulin-independent diabetes mellitus: General considerations
HE Lebovitz, MN Feinglos |
Metabolism | 1980 |
Gastric Inhibitory Polypeptide (GIP) and Insulin Release after Small-Bowel Resection in Man
KB Lauritsen, AJ Moody, KC Christensen, SL Jensen |
Scandinavian Journal of Gastroenterology | 1980 |
Secretory effects of gastrins on isolated perfused porcine pancreas
SL Jensen, JF Rehfeld, JJ Holst, J Fahrenkrug, OV Nielsen, OB de Muckadell |
American journal of physiology. Endocrinology and metabolism | 1980 |
Augmentation of Insulin Secretion by a Non-Nutrient Drink
NJ Goldberg, TD Wingert, SR Levin, RI Adachi |
Gastroenterology | 1980 |
The Entero-insular Axis and the Metabolic Effects of Gastro-enteropancreatic Polypeptides
J Dupré |
1980 | |
Gastric Inhibitory Polypeptide
R Ebert, W Creutzfeldt |
1980 | |
Heterogeneity of plasma IRI responses in patients with IGT
K Kosaka, Y Akanuma |
Diabetologia | 1980 |
Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes
R DeFronzo, D Deibert, R Hendler, P Felig, V Soman |
Journal of Clinical Investigation | 1979 |
The incretin concept today
W Creutzfeldt |
Diabetologia | 1979 |
Evidence for a regulatory role of the stomach in islet cell function
V Schusdziarra, D Rouiller, RH Unger |
Life Sciences | 1979 |
Diabetes, blood lipids, lipoproteins, and change of environment: Restudy of the “new immigrant Yemenites” in Israel
AM Cohen, J Fidel, B Cohen, A Furst, S Eisenberg |
Metabolism | 1979 |
Evaluation of insulin secretory capacity in diabetes mellitus
DL Horwitz, AH Rubenstein |
Human Pathology | 1979 |
8 GIP and the entero-insular axis
JC Brown, SC Otte |
Clinics in Endocrinology and Metabolism | 1979 |
Early insulin release following suckling in neonatal lambs and rabbits
RJ Porter, JM Bassett |
Diabetologia | 1979 |
Increased glucose disposal after jejuno-ileostomy
JF Rehfeld, KB Lauritsen, JJ Holst |
Diabetologia | 1979 |
Clinical studies with gastric inhibitory polypeptide
JC Brown, S Otte |
World Journal of Surgery | 1979 |
Chirurgisches Forum ’79
F Linder, HD Röher, U Mittmann |
1979 | |
Oral Glucose Augmentation of Insulin Secretion INTERACTIONS OF GASTRIC INHIBITORY POLYPEPTIDE WITH AMBIENT GLUCOSE AND INSULIN LEVELS
DK Andersen, D Elahi, JC Brown, JD Tobin, R Andres |
Journal of Clinical Investigation | 1978 |
I.V. Glucose tolerance test: Correlation between FFA, glucose and IRI in normal, obese and diabetic subjects
R Prando, R Cordera, A Micheli, M Maiello, P Odetti, G Viviani, L Corsi, L Adezati |
Acta Diabetologica Latina | 1978 |
Exploration of the early insulin response by two small successive loads of I.V. glucose in normal and obese subjects
R Prando, R Cordera, P Odetti, A Micheli, M Maiello, G Viviani, L Adezati |
Acta Diabetologica Latina | 1978 |
Duplication of the blood glucose curve of an OGTT in dogs by a prospectively programmed I.V. infusion: Infusion pattern and IRI response
U Fischer, EJ Freyse, E Salzsieder, G Albrecht |
Acta Diabetologica Latina | 1978 |
LACK OF A GASTROINTESTINAL MEDIATOR OF INSULIN ACTION IN MATURITY-ONSET DIABETES
R Defronzo, J Wahren, E Ferrannini, P Felig |
The Lancet | 1978 |
Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange
RA DeFronzo, E Ferrannini, R Hendler, J Wahren, P Felig |
Proceedings of the National Academy of Sciences | 1978 |
Myosins of secretory tissues
RE Ostlund, JT Leung, DM Kipnis |
The Journal of Cell Biology | 1978 |
Initial splanchnic extraction of ingested glucose in normal man
J Radziuk, TJ McDonald, D Rubenstein, J Dupre |
Metabolism | 1978 |
Pathogenesis of glucose intolerance in uremia
RA DeFronzo |
Metabolism | 1978 |
Blood insulin responses to blood glucose levels in high output sepsis and septic shock
GH Clowes, H Martin, S Walji, E Hirsch, R Gazitua, R Goodfellow |
The American Journal of Surgery | 1978 |
Temporal characteristics of insulin: Glucose ratio after varying degrees of stress and trauma in man
MM Meguid, F Aun, JS Soeldner |
Journal of Surgical Research | 1978 |
Relationship between two stages of prandial insulin release in rats
J Louis-Sylvestre |
American journal of physiology. Endocrinology and metabolism | 1978 |
Secretory effects of secretin on isolated perfused porcine pancreas
SL Jensen, J Fahrenkrug, JJ Holst, C Kühl, OV Nielsen, OB de Muckadell |
American journal of physiology. Endocrinology and metabolism | 1978 |
Diminished gastrointestinal potentiation of insulin secretion in human pregnancy
P Hornnes, C Khl, JG Klebe |
Diabetologia | 1978 |
Klinik der inneren Sekretion
A Labhart |
1978 | |
Dynamics of insulin secretion in dogs with alloxan diabetes
LN Dagaeva, FS Belikova, OI Podotykina, AV Makarova |
Bulletin of Experimental Biology and Medicine | 1978 |
Effect of secretin on basal- and glucose-stimulated insulin secretion in man.
Fahrenkrug J, Schaffalitzky de Muckadell OB, Kühl C |
Diabetologia | 1978 |
DIABETES: THE QUEST FOR BASAL NORMOGLYCÆMIA
RR Holman, RC Turner |
The Lancet | 1977 |
Pancreatic alpha and beta cell functions in cystic fibrosis
BM Lippe, MA Sperling, RR Dooley |
The Journal of Pediatrics | 1977 |
Normalization of Insulin Delivery to Diabetics by Pulsed Insulin Infusion
P Martin, S Genuth |
IEEE Transactions on Biomedical Engineering | 1977 |
Lack of gastrointestinal enhancement of the insulin response to glucose in newborn infants
KC King, R Schwartz, K Yamaguchi, PA Adam |
The Journal of Pediatrics | 1977 |
The Chemical Senses and Nutrition
WI DeWYS |
The Chemical Senses and Nutrition | 1977 |
A nonlinear model of the carbohydrate metabolism regulation system for oral and intravenous glucose tolerance test
C Cobelli, G Federspil, G Pacini, A salvan, C Scandellari |
IFAC Proceedings Volumes | 1977 |
Glucose control of basal insulin secretion in diabetes
ST McCarthy, E Harris, RC Turner |
Diabetologia | 1977 |
Extrapancreatic and pancreatic actions of glibenclamide in rats
W Heptner, A Zermatten, , O Christ, |
Diabetologia | 1977 |
Diabetes mellitus • B
R Beckmann, M Berger, A Beringer, P Berchtold, J Beyer, A Bischoff, G Brehm, BF Clarke, GR Constam, LJ Duncan, FA Gries, A Hasselblatt, R Hild, K Irmscher, K Jahnke, J Kühnau, H Liebermeister, K Lundbaek, G Meyer-Schwickerath, S Napp-Mellinghoff, M Neubauer, F Nobbe, K Oberdisse, P Petrides, R Petzoldt, H Sauer, K Schöffling, M Spitznas, J Steinke, M Vogel, KH Vogelberg, A Wessing |
1977 | |
Disturbed islet-cell function related to endogenous gastrin release. Studies on insulin secretion and glucose tolerance in pernicious anemia
JF Rehfeld |
Journal of Clinical Investigation | 1976 |
7Carbohydrate metabolism in liver disease
DG Johnston, KG Alberti |
Clinics in Endocrinology and Metabolism | 1976 |
1Carbohydrate metabolism in vivo: Regulation of the blood glucose level
EA Newsholme |
Clinics in Endocrinology and Metabolism | 1976 |
The Year in Metabolism 1975–1976
N Freinkel |
1976 | |
The enteral insulin-stimulation after pancreas transplantation in the pig
SL Jensen, OV Nielsen, C Khl |
Diabetologia | 1976 |
Glucagon, insulin and growth hormone response in obese women
F Fallucca, G Menzinger, S Gambardella, S Tamburrano, D Andreani |
Acta Diabetologica Latina | 1975 |
Aktuelle Ansichten über die Fettsuchtpathologie
A Bučko |
Food / Nahrung | 1975 |
The Glucose-Induced Gastrointestinal Stimulation of Insulin Secretion in Man: Relation to Age and to Gastrin Release
JF Rehfeld, F Stadil |
European Journal of Clinical Investigation | 1975 |
Effects of portacaval anastomosis on glucose tolerance in the dog: Evidence of an interaction between the gut and the liver in oral glucose disposal
HL Lickley, DJ Chisholm, A Rabinovitch, M Wexler, J Dupre |
Metabolism | 1975 |
Glucose consumption by red cells of diabetic patients and normal subjects. Effect of ethanol
GB Phillips, PB Mendershausen |
Clinica Chimica Acta | 1975 |
Diabetic glomerulosclerosis without glucose intolerance
DA Nash, PW Rogers, PC Langlinais, SM Bunn |
The American Journal of Medicine | 1975 |
Effects of ethanol ingestion on glucose tolerance and insulin secretion in normal and diabetic subjects
J McMonagle, P Felig |
Metabolism | 1975 |
Proceedings of the 1974 Laurentian Hormone Conference
H Valtin, HW Sokol, D Sunde |
Proceedings of the 1974 Laurentian Hormone Conference | 1975 |
Physiology of Diabetes
NK Maclaren, M Cornblath |
Pediatric Annals | 1975 |
Diabetes mellitus · A
E Cerasi, P Dieterle, H Ege, A Englhardt, H Frerichs, W Gepts, A Hasselblatt, HR Henrichs, L Herberg, JJ Hoet, H Hungerland, K Jahnke, RJ Jarrett, G Jörgensen, KH Jørgensen, H Kasemir, H Keen, L Kerp, V Leclercq-Meyer, H Liebermeister, G Löffler, R Luft, WJ Malaisse, J Markussen, M Möllering, H Schadewaldt, J Schlichtkrull, K Schöffling, U Schwedes, PC Scriba, F Sundby, KH Usadel, L Weiss, H Zimmermann, K Oberdisse |
1975 | |
The enteral insulin-stimulation after whipple's operation
JF Rehfeld, F Stadil, H Baden, K Fischerman |
Diabetologia | 1975 |
Cholinergic Modification of Glucose-Induced Biphasic Insulin Release in Vitro
R Sharp, S Culbert, J Cook, A Jennings, IM Burr |
Journal of Clinical Investigation | 1974 |
THE RELATION BETWEEN A LARGE BABY AT BIRTH AND DIMINISHED MATERNAL FIRST PHASE INSULIN RESPONSE TO GLUCOSE
RS Ledward, PJ Paterson, RC Turner |
BJOG: An International Journal of Obstetrics and Gynaecology | 1974 |
Carbohydrate tolerance and insulin responses in obstructive jaundice
NG Soler, PD Exon, A Paton |
British medical journal | 1974 |
A radioimmunoassay for plasma insulin using zirconyl phosphate gel
JW Coffey, CF Nagy, R Lenusky, HJ Hansen |
Biochemical Medicine | 1974 |
The Biology of Alcoholism
B Kissin, H Begleiter |
1974 | |
Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range
K Kosaka, R Hagura, T Kuzuya, N Kuzuya |
Diabetologia | 1974 |
Candidate Hormones of the Gut
MI Grossman |
Gastroenterology | 1974 |
The Different Effects on the Serum Lipids and Fecal Steroids of High Carbohydrate Diets Given Orally or Intravenously
L DenBesten, RH Reyna, WE Connor, LD Stegink |
Journal of Clinical Investigation | 1973 |
The Effect of Gastrin on Basal- and Glucose-Stimulated Insulin Secretion in Man
JF Rehfeld, F Stadil |
Journal of Clinical Investigation | 1973 |
Insulin Sensitivity of Forearm Tissues in Prediabetic Man
T Pozefsky, MR Santis, JS Soeldner, RG Tancredi |
Journal of Clinical Investigation | 1973 |
THE SPECTRUM OF PLASMA INSULIN RESPONSES IN MIDDLE-AGED AND OLD NON-OBESE DIABETICS WITH VARIOUS DEGREES OF METABOLIC DERANGEMENT
K Johansen |
Acta Medica Scandinavica | 1973 |
Physical Training in Human Obesity II. Effects on Plasma Insulin in Glucose-Intolerant Subjects without Marked Hyperinsulinemia
P Björntorp, K Jounge, L Sjöström, L Sullivan |
Scandinavian Journal of Clinical & Laboratory Investigation | 1973 |
Coronary Heart Disease in Young Men: A Study of Seventy Patients with a Critical Review of Etiological Factors*
RB Blacket, B Leelarthaepin, AJ Palmer, JM Woodhill |
Australian and New Zealand Journal of Medicine | 1973 |
The role of carbohydrate and oral agents in the treatment of diabetes mellitus
WD Odell |
California medicine | 1973 |
Portal diversion for the treatment of glycogen storage disease in humans
TE Starzl, CW Putnam, KA Porter, CG Halgrimson, J Corman, BI Brown, RW Gotlin, DO Rodgerson, HL Greene |
Annals of Surgery | 1973 |
Alimentary hypoglycemia associated with the Zollinger-Ellison syndrome
TK O'Brien, G Tijtgat, JW Ensinck |
The American Journal of Medicine | 1973 |
Disassociation of the plasma insulin response from the blood glucose concentration during glucose infusions in normal dogs
J Olefsky, T Batchelder, JW Farquhar, GM Reaven |
Metabolism | 1973 |
Carbohydrate Metabolism and Acute Myocardial Infarction: Circulating Glucose, Insulin, Cortisol and Growth Hormone Responses and Excretion of Catecholamines
TL Kurt, E Genton, C Chidsey, P Beck, KE Sussman |
Chest | 1973 |
Neunundsiebzigster Kongress: Gehalten zu Wiesbaden vom 29. April – 3. Mai 1973
K Miehlke |
1973 | |
Aktuelle Ernährungswissenschaftliche Probleme
KH Bässler, G Siebert |
1973 | |
Suppressive effect of secretin upon pancreatic alpha cell function
F Santeusanio, GR Faloona, RH Unger |
Journal of Clinical Investigation | 1972 |
Energy metabolism and electrolytes during thiopentone meperidine anaesthesia in normal man
EA Moffitt, AD Sessler, RS Goldsmith, RJ Ryan, K Rehder |
Canadian Anaesthetists’ Society Journal | 1972 |
INSULIN SECRETION AFTER TOLBUTAMIDE AND AFTER SECRETIN IN PATIENTS WITH PANCREATIC DISEASES
T Deckert, K Kølendorf, I Persson, H Worning |
Acta Medica Scandinavica | 1972 |
The effect of portacaval anastomosis on oral carbohydrate tolerance and on plasma insulin levels
CD Holdsworth, L Nye, E King |
Gut | 1972 |
Changes in glucose tolerance and serum insulin following partial gastrectomy and intestinal resection
S Wapnick, JJ Jones |
Gut | 1972 |
Correlations between plasma insulin and body weight in obesity, anorexia nervosa and diabetes mellitus
F Stephan, P Reville, R Thierry, JL Schlienger |
Diabetologia | 1972 |
Insulin secretion and body composition in obesity
AZ El-Khodary, MF Ball, IM Oweiss, JJ Canary |
Metabolism | 1972 |
Gastrointestinal Hormones and Insulin Secretion
JF Rehfeld |
Scandinavian Journal of Gastroenterology | 1972 |
Effect of exogenous estrogen on carbohydrate metabolism in postmenopausal women
LN Ajabor, CC Tsai, P Vela, SS Yen |
American Journal of Obstetrics and Gynecology | 1972 |
Insulin secretion in obesity after exercise
M Fahln, J Stenberg, P Bjrntorp |
Diabetologia | 1972 |
Gastric Operations and Glucose Homeostasis
RI Breuer, H Moses, TC Hagen, L Zuckerman |
Gastroenterology | 1972 |
Insulin Insensitivity of Large Fat Cells
JN Livingston, P Cuatrecasas, DH Lockwood |
Science | 1972 |
The Mechanism of insulin secretion after oral glucose administration: I. Multiphasic course of insulin mobilization after oral administration of glucose in conscious dogs. Differences to the behaviour after intravenous administration
U Fischer, H Hommel, M Ziegler, R Michael |
Diabetologia | 1972 |
Analytical review: The pathogenesis of diabetes mellitus and its relationship to biological aging
S Goldstein |
Human Genetics | 1971 |
Insulinmobilisierung beim Hund durch Scheinfütterung mit Glukose
U Fischer, H Hommel |
Experientia | 1971 |
Cirrhosis and diabetes
HO Conn, W Schreiber, SG Elkington |
The American Journal of Digestive Diseases | 1971 |
The Glucose Uptake of Human Adipose Tissue in Obesity
P Bjöentorp, P Berchtold, J Holm, B Larsson |
European Journal of Clinical Investigation | 1971 |
ON THE ROLE OF CYCLIC AMP IN INSULIN RELEASE: II. DYNAMIC ASPECTS AND RELATIONS TO ADRENERGIC RECEPTORS IN THE PERIFUSED PANCREAS OF ADULT RATS*
IM Burr, HP Taft, W Stauffacher, AE Renold |
Annals of the New York Academy of Sciences | 1971 |
Diabetes survey plasma insulin during 0-2h oral glucose tolerance test systematically carried out in a professional group
GE Rosselin, JR Claude, EP Eschwege, E Patois, JM Warnet, JL Richard |
Diabetologia | 1971 |
A CONTROLLED STUDY OF PERORAL GLUCOSE, INSULIN AND POTASSIUM TREATMENT IN MYOCARDIAL INFARCTION
I Hjermann |
Acta Medica Scandinavica | 1971 |
Changes in plasma insulin related to the type of dietary carbohydrate in overweight hyperlipidemic male patients
NW Rodger, BP Squires, EL Du |
Canadian Medical Association journal | 1971 |
Determinants of insulin response to glucose absorption from human small bowel
AL Blum, WG Linscheer |
Metabolism | 1971 |
Effect of feeding on intravenous glucose tolerance and insulin response in piglets during the first day of life
J Gentz, B Persson, M Kellum, G Bengtsson, J Thorell |
Life Sciences | 1971 |
Effect of Diet Composition on the Hyperinsulinemia of Obesity
N Grey, DM Kipnis |
New England Journal of Medicine | 1971 |
Studies of Chlormadinone Acetate and Mestranol on Blood Glucose and Plasma Insulin. II. Twelfth Month Oral Glucose Tolerance Test**These studies were supported in part by funds from the Public Health Service, Consumer Protection and Environmental Health Service, Food and Drug Administration, and Department of Health, Education, and Welfare, under Contract CPF 69-32
WN Spellacy, WC Buhi, SA Birk, SA McCreary |
Fertility and Sterility | 1971 |
Adrenergic Modification of Glucose-Induced Biphasic Insulin Release from Perifused Rat Pancreas
IM Burr, L Balant, W Stauffacher, AE Renold |
European Journal of Clinical Investigation | 1971 |
The Pattern of Plasma Insulin Response to Glucose in Patients with a Previous Myocardial Infarction-The Respective Effects of Age and Disease
C Malherbe, M Gasparo, P Berthet, R Hertogh, JJ Hoet |
European Journal of Clinical Investigation | 1971 |
Diabetes survey plasma insulin during 0-2h oral glucose tolerance test systematically carried out in a professional group: I. Relationship with plasma glucose, free fatty acids, cholesterol, triglycerides and corpulence
GE Rosselin, JR Claude, EP Eschwege, E Patois, JM Warnet, JL Richard |
Diabetologia | 1971 |
Cirrhosis and diabetes: II. Association of impaired glucose tolerance with portal-systemic shunting in Laennec's cirrhosis
HO Conn, W Schreiber, SG Elkington |
The American Journal of Digestive Diseases | 1971 |
The significance and interpretation of mildly abnormal oral glucose tolerance.
Alford FP, Martin FI, Pearson MJ |
Diabetologia | 1971 |
The gastrointestinal stimulus to insulin release II. A dual action of secretin
EW Kraegen, DJ Chisholm, JD Young, L Lazarus |
Journal of Clinical Investigation | 1970 |
The effect of fasting, diet, and actinomycin D on insulin secretion in the rat
NJ Grey, S Goldring, DM Kipnis |
Journal of Clinical Investigation | 1970 |
Perifusion of rat pancreatic tissue in vitro: substrate modification of theophylline-induced biphasic insulin release
IM Burr, L Balant, W Stauffacher, AE Renold |
Journal of Clinical Investigation | 1970 |
VIII—INSULIN AND GLUCOSE HOMŒOSTASIS
KJ Catt |
The Lancet | 1970 |
PLASMA-INSULIN AFTER TOLBUTAMIDE IN DIABETICS AND NON-DIABETICS
T Deckert, P Mogensen |
Acta Medica Scandinavica | 1970 |
Lessons of epidemiology of diabetes
RJ Jarrett |
British medical journal | 1970 |
Plasma triglyceride response to carbohydrates, fats and caloric intake
PJ Nestel, KF Carroll, N Havenstein |
Metabolism | 1970 |
The effect of physical training on insulin production in obesity
P Björntorp, K Jounge, L Sjöström, L Sullivan |
Metabolism | 1970 |
Early Diabetes
JM Stowers |
Early Diabetes | 1970 |
Effect of Gastrointestinal Hormones on Insulin and Glucagon Secretion
W Creutzfeldt, G Feurle, H Ketterer |
New England Journal of Medicine | 1970 |
Carbohydrate Homeostasis
R Levine, DE Haft |
New England Journal of Medicine | 1970 |
Glucose, insulin, and growth hormone studies in long-term users of oral contraceptives
WN Spellacy, WC Buhi, CE Spellacy, LE Moses, JW Goldzieher |
American Journal of Obstetrics and Gynecology | 1970 |
The role of the portal circulation in glucose and fructose tolerance
N McIntyre, DS Turner, CD Holdsworth |
Diabetologia | 1970 |
The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects
JD Bigelow-Sherman, K Shima, EK Borden, R Penhallegon, PP Foà |
Acta Diabetologica | 1970 |
Les ripostes insulinémiques au glucose veineux et oral dans diverses formes de diabète sucré
J Mirouze, A Orsetti, H Lapinski |
Acta Diabetologica | 1970 |
Myocardial metabolism in open-heart surgery
EA Moffitt, JW Rosevear, GD Molnar, DC McGoon |
The Journal of Thoracic and Cardiovascular Surgery | 1970 |
STANDARDIZATION AND EVALUATION OF THE ORAL GLUCOSE TOLERANCE TEST
NG Carter, JH Maynard |
The Medical Journal of Australia | 1970 |
The Intestinal Insulinotropic Action after Jejuno-Ileostomy
JF Rehfeld, E Juhl, F Quaade |
Scandinavian Journal of Gastroenterology | 1970 |
Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man
J Dupre, JD Curtis, RH Unger, RW Waddell, JC Beck |
Journal of Clinical Investigation | 1969 |
The gastrointestinal stimulus to insulin release I. Secretin
DJ Chisholm, JD Young, L Lazarus |
Journal of Clinical Investigation | 1969 |
Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose
CJ Goodner, MJ Conway, JH Werbach |
Journal of Clinical Investigation | 1969 |
Diabetogenic action of streptozotocin: relationship of dose to metabolic response
A Junod, AE Lambert, W Stauffacher, AE Renold |
Journal of Clinical Investigation | 1969 |
Oral glucose tolerance and related factors in a normal population sample. II. Interrelationship of glycerides, cholesterol, and other factors with the glucose and insulin response
ME Abrams, RJ Jarrett, H Keen, DR Boyns, JN Crossley |
British medical journal | 1969 |
Type III hyperlipoproteinemia with low plasma thyroxine binding globulin
J Dyerberg |
Metabolism | 1969 |
Effects of various routes of caffeine administration on oral and intravenous glucose tolerance tests in dogs
OA DeCastro, H Sandberg, LJ Feinberg, S Bellet |
Metabolism | 1969 |
Fat cell function and insulin in a patient with generalized lipodystrophy
Boris, L Loridan |
The Journal of Pediatrics | 1969 |
Oral Glucose Tolerance Curve and Hypoglycemias in the Fed State
N Freinkel, BE Metzger |
New England Journal of Medicine | 1969 |
Insulin patterns prior to and after onset of diabetes
TS Danowski, YB Lombardo, LV Mendelsohn, DG Corredor, CR Morgan, G Sabeh |
Metabolism | 1969 |
Growth hormone and insulin levels in newly discovered glucose intolerance
G Sabeh, DG Corredor, LV Mendelsohn, CR Morgan, JC Sieracki, JH Sunder, JP Wingert, TS Danowski |
Metabolism | 1969 |
The diagnosis of diabetes mellitus
H Keen |
Journal of clinical pathology. Supplement (Association of Clinical Pathologists) | 1969 |
A Study of Carbohydrate Metabolism in Scleroderma**From the Sections of Dermatologyt and Endocrinology and Metabolism, Departmeot of Medicine, Hahnemann Medical College and Hospital, Philadelphia, Penna. 19102
R Fleischmajer, G Faludi |
Journal of Investigative Dermatology | 1969 |
A review of carbohydrate metabolism and the oral contraceptives
WN Spellacy |
American Journal of Obstetrics and Gynecology | 1969 |
The role of the liver in the disposal of orally administered 14C-glucose in the normal rat
SL Jeffcoate, AJ Moody |
Diabetologia | 1969 |
ALIMENTARY FACTORS IN THE ENDOCRINE RESPONSE TO ADMINISTRATION OF ARGININE IN MAN
J Dupré, JD Curtis, RW Waddell, JC Beck |
The Lancet | 1968 |
STRUCTURE OF THE VERVET-MONKEY-DISEASE AGENT
I Zlotnik, DI Simpson, DM Howard |
The Lancet | 1968 |
Effects of coffee ingestion on oral glucose tolerance curves in normal human subjects
LJ Feinberg, H Sandberg, OD Castro, S Bellet |
Metabolism | 1968 |
Normal Growth with Subnormal Growth-Hormone Levels
LB Holmes, AG Frantz, MT Rabkin, JS Soeldner, JD Crawford |
New England Journal of Medicine | 1968 |
Advances in Metabolic Disorders
G Aurbach, JT Potts |
Advances in Metabolic Disorders | 1964 |
Insulin Resistance
A Voll, J Kloster |
Acta Medica Scandinavica | 1957 |